<html lang="en"><head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <link rel="shortcut icon" href="./favicon.png">
    <link rel="preload" href="./static/media/SourceSansPro-Regular.DZLUzqI4.woff2" as="font" type="font/woff2" crossorigin="">
    <link rel="preload" href="./static/media/SourceSansPro-SemiBold.sKQIyTMz.woff2" as="font" type="font/woff2" crossorigin="">
    <link rel="preload" href="./static/media/SourceSansPro-Bold.-6c9oR8J.woff2" as="font" type="font/woff2" crossorigin="">

    <title>app</title>

    <!-- initialize window.prerenderReady to false and then set to true in React app when app is ready for indexing -->
    <script>
      window.prerenderReady = false
    </script>
    <script type="module" crossorigin="" src="./static/js/index.BlylrL8P.js"></script>
    <link rel="stylesheet" crossorigin="" href="./static/css/index.DpJG_94W.css">
  <style media=""></style><style data-emotion="st-emotion-cache-global" data-s=""></style><style data-emotion="st-emotion-cache" data-s=""></style><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/index.BqlD3NTA.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/index.DW_MHI2K.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/FormClearHelper.UtDFKbpT.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/FileHelper.DV2KuUj6.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/ProgressBar.BtMHwdZZ.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/Hooks.YZgOFmbn.js"><link rel="modulepreload" as="script" crossorigin="" href="https://pieree369-olmocr.hf.space/static/js/UploadFileInfo.C-jY39rj.js"></head>
  <body>
    <noscript>You need to enable JavaScript to run this app.</noscript>
    <div id="root"><div class=""><div class="withScreencast" data-testid="stScreencast"><div class="stApp stAppEmbeddingId-t7j58i34wms7 st-emotion-cache-1r4qj8v ee4bbma0" data-testid="stApp" data-test-script-state="notRunning" data-test-connection-state="CONNECTED"><header tabindex="-1" class="stAppHeader st-emotion-cache-12fmjuu e4hpqof0" data-testid="stHeader"><div class="stDecoration st-emotion-cache-1dp5vir e4hpqof1" data-testid="stDecoration" id="stDecoration"></div><div class="stAppToolbar st-emotion-cache-15ecox0 e4hpqof2" data-testid="stToolbar"><div class="stToolbarActions st-emotion-cache-1p1m4ay e1i26tt72" data-testid="stToolbarActions"></div><span id="MainMenu" class="stMainMenu st-emotion-cache-czk5ss ev04twb8" data-testid="stMainMenu" aria-haspopup="true" aria-expanded="false"><button kind="headerNoPadding" data-testid="stBaseButton-headerNoPadding" aria-label="" class="st-emotion-cache-l1ktzw em9zgd018"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="e144pc0f1 st-emotion-cache-1pbsqtx ex0cdmw0"><path fill="none" d="M0 0h24v24H0V0z"></path><path d="M12 8c1.1 0 2-.9 2-2s-.9-2-2-2-2 .9-2 2 .9 2 2 2zm0 2c-1.1 0-2 .9-2 2s.9 2 2 2 2-.9 2-2-.9-2-2-2zm0 6c-1.1 0-2 .9-2 2s.9 2 2 2 2-.9 2-2-.9-2-2-2z"></path></svg></button></span></div></header><div class="stAppViewContainer appview-container st-emotion-cache-1yiq2ps eht7o1d0" data-testid="stAppViewContainer" data-layout="narrow"><section tabindex="0" class="stMain st-emotion-cache-bm2z3a eht7o1d1" data-testid="stMain"><div class="stMainBlockContainer block-container st-emotion-cache-mtjnbi eht7o1d4" data-testid="stMainBlockContainer"><div data-testid="stVerticalBlockBorderWrapper" data-test-scroll-behavior="normal" class="st-emotion-cache-0 eu6p4el5"><div class="st-emotion-cache-b95f0i eu6p4el4"><div class="stVerticalBlock st-emotion-cache-1n76uvr eu6p4el3" data-testid="stVerticalBlock" width="704"><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="stHeading" data-testid="stHeading"><div data-testid="stMarkdownContainer" class="st-emotion-cache-1104ytp e1icttdg0"><div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 id="olmocr">OLMOCR<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#olmocr" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div></div></div></div><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="st-emotion-cache-8atqhb e1mlolmg0"><div class="stFileUploader st-emotion-cache-0 e17y52ym15" data-testid="stFileUploader" width="704"><label data-testid="stWidgetLabel" aria-hidden="true" class="st-emotion-cache-1s2v671 e1dx5vew0"><div data-testid="stMarkdownContainer" class="st-emotion-cache-wq5ihp e1icttdg0"><p>Upload a PDF or Image</p></div></label><section role="presentation" tabindex="0" data-testid="stFileUploaderDropzone" aria-label="Upload a PDF or Image" class="st-emotion-cache-1gulkj5 e17y52ym0"><input data-testid="stFileUploaderDropzoneInput" accept="application/streamlit,.pdf,.png,.jpg,.jpeg" type="file" style="border: 0px; clip: rect(0px, 0px, 0px, 0px); clip-path: inset(50%); height: 1px; margin: 0px -1px -1px 0px; overflow: hidden; padding: 0px; position: absolute; width: 1px; white-space: nowrap;" tabindex="-1"><div data-testid="stFileUploaderDropzoneInstructions" class="st-emotion-cache-u8hs99 e17y52ym1"><span class="st-emotion-cache-nwtri e17y52ym2"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="e144pc0f1 st-emotion-cache-6rlrad ex0cdmw0"><path fill="none" d="M0 0h24v24H0V0z"></path><path d="M19.35 10.04A7.49 7.49 0 0012 4C9.11 4 6.6 5.64 5.35 8.04A5.994 5.994 0 000 14c0 3.31 2.69 6 6 6h13c2.76 0 5-2.24 5-5 0-2.64-2.05-4.78-4.65-4.96zM19 18H6c-2.21 0-4-1.79-4-4 0-2.05 1.53-3.76 3.56-3.97l1.07-.11.5-.95A5.469 5.469 0 0112 6c2.62 0 4.88 1.86 5.39 4.43l.3 1.5 1.53.11A2.98 2.98 0 0122 15c0 1.65-1.35 3-3 3zM8 13h2.55v3h2.9v-3H16l-4-4z"></path></svg></span><div class="st-emotion-cache-j7qwjs e17y52ym4"><span class="st-emotion-cache-9ycgxx e17y52ym3">Drag and drop file here</span><small class="st-emotion-cache-1rpn56r ejh2rmr0">Limit 200MB per file • PDF, PNG, JPG, JPEG</small></div></div><button kind="secondary" data-testid="stBaseButton-secondary" aria-label="" class="st-emotion-cache-ocsh0s em9zgd02">Browse files</button></section><div class="st-emotion-cache-fis6aj e17y52ym5"><ul class="st-emotion-cache-14m29r0 e17y52ym6"><li class="st-emotion-cache-1l95nvm e17y52ym7"><div class="stFileUploaderFile st-emotion-cache-12xsiil e17y52ym10" data-testid="stFileUploaderFile"><div class="st-emotion-cache-10ix4kq e17y52ym12"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="e144pc0f1 st-emotion-cache-4mjat2 ex0cdmw0"><path fill="none" d="M0 0h24v24H0V0z"></path><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zM6 20V4h7v5h5v11H6z"></path></svg></div><div class="stFileUploaderFileData st-emotion-cache-1l4firl e17y52ym8"><div class="stFileUploaderFileName st-emotion-cache-1uixxvy e17y52ym9" data-testid="stFileUploaderFileName" title="medical-microbiology-virosoly.pdf">medical-microbiology-virosoly.pdf</div><small class="st-emotion-cache-1rpn56r ejh2rmr0">4.7MB</small></div><div data-testid="stFileUploaderDeleteBtn"><button kind="minimal" data-testid="stBaseButton-minimal" aria-label="" class="st-emotion-cache-8ccstr em9zgd06"><svg viewBox="0 0 24 24" aria-hidden="true" focusable="false" fill="currentColor" xmlns="http://www.w3.org/2000/svg" class="e144pc0f1 st-emotion-cache-1pbsqtx ex0cdmw0"><path fill="none" d="M0 0h24v24H0V0z"></path><path d="M19 6.41L17.59 5 12 10.59 6.41 5 5 6.41 10.59 12 5 17.59 6.41 19 12 13.41 17.59 19 19 17.59 13.41 12 19 6.41z"></path></svg></button></div></div></li></ul></div></div></div></div><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="stButton st-emotion-cache-8atqhb e1mlolmg0" data-testid="stButton"><button kind="secondary" data-testid="stBaseButton-secondary" aria-label="" class="st-emotion-cache-ocsh0s em9zgd02"><div data-testid="stMarkdownContainer" class="st-emotion-cache-1hyd1ho e1icttdg0"><p>Submit</p></div></button></div></div><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="stMarkdown" data-testid="stMarkdown"><div data-testid="stMarkdownContainer" class="st-emotion-cache-1104ytp e1icttdg0"><p><strong>Processing file:</strong> medical-microbiology-virosoly.pdf</p></div></div></div><div class="stElementContainer element-container st-emotion-cache-kj6hex eu6p4el1" data-testid="stElementContainer" data-stale="false" width="auto"><div class="stMarkdown" data-testid="stMarkdown"><div data-testid="stMarkdownContainer" class="st-emotion-cache-1104ytp e1icttdg0"><p><img src="assets/images/image-20251219-cbd67257.jpeg" alt="img-0.jpeg"></p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="medical-microbiology">Medical Microbiology<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#medical-microbiology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Part Two: Medical Virology</p>
<p>Scanned by CamScanner</p>
<p>Chapter 1
Introduction</p>
<p>Viruses are the smallest infectious agents measuring 20 to 300 nm in diameter. They are obligate intracellular parasites and contain no enzymes necessary for energy metabolism. They are entirely dependant on the host cell for biosynthesis of macromolecules. A virus contains only one of the two nucleic acids, deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The nucleic acid is encased in a protein shell, which may again be surrounded by a lipid-containing membrane.</p>
<p>Viruses might have evolved from free living cells, or they might have been components of host cells which separated and started independent existence. They behave like 'living chemicals' and are the best tools to understand the chemistry of life. Viruses infect unicellular organisms such as bacteria and algae, and all higher plants and animals. The range of hosts an individual virus can attack may be extremely limited, or very large. Major differences between bacteria and viruses are listed in Table 1.1.</p>
<p>The medical importance of viruses lies in their capacity to cause a wide variety of human diseases, ranging from minor ailments such as the common cold to highly fatal diseases such as yellow fever.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="morphology-of-viruses">MORPHOLOGY OF VIRUSES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#morphology-of-viruses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="size">Size<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#size" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Viruses differ from bacteria by their ability to pass through filters that hold back bacteria. With the exception of some larger viruses, they are usually</p>
<p>Table 1.1 Differences in characteristics of bacteria and viruses</p>
<table><thead><tr><th></th><th>Bacteria</th><th>Viruses</th></tr></thead><tbody><tr><td>1. Cellular organisation</td><td>+</td><td>—</td></tr><tr><td>2. Presence of both DNA and RNA</td><td>+</td><td>—</td></tr><tr><td>3. Reproduction by binary fission</td><td>+</td><td>—</td></tr><tr><td>4. Growth on inanimate media</td><td>+</td><td>—</td></tr><tr><td></td><td>(except <em>chlamydiae</em> and <em>rickettsiae</em>)</td><td>—</td></tr><tr><td>5. Sensitivity to antibiotics</td><td>+</td><td>—</td></tr><tr><td>6. Sensitivity to interferon</td><td>+</td><td>+</td></tr><tr><td></td><td>(except <em>chlamydiae</em>)</td><td>+</td></tr></tbody></table>
<p>Scanned by CamScanner</p>
<p>860 Medical Virology</p>
<p>too small to be seen with the light microscope, and hence are called ‘ultramicroscopic’. The size of a virus can be measured in a number of ways:</p>
<p>(i) Filtration through collodion membranes of graded porosity.
(ii) Direct observation and measurement in the electron microscope.
(iii) Determination of the sedimentation rate in the ultracentrifuge.
(iv) Comparative measurements with other microorganisms of known sizes (Fig. 1.1).</p>
<p>The size of viruses ranges from 20 nm to 300 nm. The poxviruses are the largest of the viruses (300 nm) which are about the same size as the smallest bacteria. Poxviruses can be seen with the light microscope, but all other viruses are visible only under the electron microscope.</p>
<p><img src="assets/images/image-20251219-a979cf94.jpeg" alt="img-1.jpeg">
Fig. 1.1 Comparative sizes of bacteria and viruses</p>
<p>Scanned by CamScanner</p>
<p>Structure</p>
<p>Introduction 861</p>
<p>The complete virus particle, virion, consists of a nucleic acid core surrounded by an impenetrable protein coat, the capsid. The capsid is composed of a large number of morphological units called capsomers. The capsid and the nucleic acid core together are known as the nucleocapsid. The capsomers are symmetrically arranged around the core. The capsid performs two main functions: it protects the core, and helps it to enter into the host cell.</p>
<p>The symmetrical arrangement of the capsid around the core is mainly of two types, icosahedral and helical (Fig. 1.2). A few viruses, for example, poxviruses, have a complex structure.</p>
<p>Icosahedral symmetry An icosahedron is a polygon with 12 vertices (corners) and 20 facets (sides), each facet being an equilateral triangle e.g. adenovirus. Icosahedral capsids are usually formed independent of nucleic acid.</p>
<p>Helical symmetry In helical symmetry, the capsomers are bound to the nucleic acid in such a way that the nucleic acid winds spirally to form a helix. Thus, unlike the icosahedral symmetry, the helical symmetry involves interaction between the nucleic acid core and the capsid, e.g. tobacco-mosaic virus, orthomyxoviruses.</p>
<p>Complex structure Some viruses do not exhibit any symmetry, but are complex in structure. For example, poxviruses are brick shaped with ridges on the external surface.</p>
<p>Envelope Some viruses have a covering or an envelope outside the capsid, and are said to be enveloped. The envelope is derived from the host cell membrane when the virus is released from the cell. The envelope is made up of lipids and proteins. The protein subunits may project from the envelope as spikes. A virus may have different types of spikes e.g. influenza virus has two types of spikes on its envelope, haemagglutinin and neuraminidase spikes.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="chemical-constituents-of-viruses">CHEMICAL CONSTITUENTS OF VIRUSES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#chemical-constituents-of-viruses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Proteins The protective covering, capsid, consists of proteins. These proteins determine the antigenic characteristics of the virus. Some proteins are in the form of enzymes. These enzymes, though present in very small amounts, are essential for the initiation of the replication cycle of the virus within the host cell. For example, some viruses contain RNA polymerase (e.g. orthomyxoviruses), while retroviruses contain reverse transcriptase, the enzyme which makes complementary DNA copy of the viral RNA.</p>
<p>Nucleic acid The nucleic acid of a virus, which is either DNA or RNA, may be single or double stranded, circular or linear in shape, and may or may not be segmented. The nucleic acid contains the genetic information necessary for the replication of the virus. The sequences and composition of nucleotides of viral nucleic acid are specific for</p>
<p><img src="assets/images/image-20251219-b7dd6f9b.jpeg" alt="img-2.jpeg"></p>
<p>Scanned by CamScanner</p>
<p>862 Medical Virology</p>
<p>each virus. These characteristics are useful in classifying the viruses into families.</p>
<p><strong>Lipids</strong> Lipids are present in the envelopes of viruses. As the envelope is formed by budding from the cell membrane of the host cell, it shows a lipid composition. Some viruses, such as herpesviruses, bud through the nuclear membrane of the host cell, and show the lipid composition of the nuclear membrane instead of that of the cell membrane.</p>
<p><strong>Carbohydrates</strong> Viral envelopes also contain glycoprotein coded by the virus itself, unlike the lipids which are derived from the host cell. These glycoproteins help the virus in attachment to the host cell. Because of their antigenic nature, the glycoproteins are also involved in the interactions with antibodies.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="classification-of-medically-important-viruses">CLASSIFICATION OF MEDICALLY IMPORTANT VIRUSES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#classification-of-medically-important-viruses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The scheme for the classification of viruses depends upon their structure, antigenic composition and other properties. Viral families and genera have been designated, though differentiation into species is still incomplete.</p>
<p>Viruses are classified into two major divisions depending on the type of nucleic acid.</p>
<p>I. Deoxyriboviruses, which contain DNA.
II. Riboviruses, which contain RNA.</p>
<p>Both of these are further subdivided mainly on the basis of size and shape of the virion, symmetry of the nucleocapsid and strandedness of the nucleic acid. Major families of viruses are briefly discussed below:</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="i-dna-viruses">I. DNA Viruses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#i-dna-viruses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="1-family-parvoviridae">1. Family Parvoviridae<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-family-parvoviridae" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<p>Size : 18–26 nm
Symmetry : Icosahedral
Envelope : Absent
DNA : Single stranded
Example : Parvovirus</p>
<p>Some members of the family cause gastroenteritis while others are associated with haemolytic disease.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="2-family-papovaviridae">2. Family Papovaviridae<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-family-papovaviridae" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<p>Size : 40–55 nm
Symmetry : Icosahedral
Envelope : Absent
DNA : Double stranded
Example:
(i) <em>Papilloma virus</em> which causes cutaneous, genital and laryngeal warts.
(ii) <em>Polyomavirus</em> which produces neurological diseases.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="3-family-adenoviridae">3. Family Adenoviridae<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-family-adenoviridae" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<p>Size : 70–90 nm
Symmetry : Icosahedral
Envelope : Absent
DNA : Double stranded
Example: Adenovirus. There are at least 41 types of adenoviruses that can infect humans. They attack the lymphoid tissue and the mucous membranes. Some adenoviruses can cause acute respiratory disease, and conjunctivitis.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h4 level="4" id="4-family-herpesviridae">4. Family Herpesviridae<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-family-herpesviridae" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h4></div>
<p>Size : 100–200 nm
Symmetry : Icosahedral
Envelope : Present
DNA : Double stranded</p>
<p>The virus shows clearly defined structural units with a central depression.</p>
<p>Examples:
(i) <em>Herpes simplex virus</em>: Herpes simplex virus type 1 may cause oral infection (gingivostomatitis) or keratitis. Herpes simplex virus type 2 causes genital lesions.
(ii) <em>Varicella/Zoster</em>: Varicella (chicken pox) is the primary infection. The virus may remain latent in the nerve ganglia, and may be reactivated when the immunity is lowered, resulting in an attack of zoster (shingles).</p>
<p>Scanned by CamScanner</p>
<p>Introduction 863</p>
<p>(iii) <em>Cytomegalovirus (CMV)</em>: Usually CMV infections are symptomless. It may cause severe generalised neonatal infection or an infection similar to glandular fever in adults. Generalised infection may occur in immunosuppressed patients, especially in AIDS.</p>
<p>(iv) <em>Epstein-Barr virus</em>: This virus causes infectious mononucleosis (glandular fever). It is also associated with Burkitt's lymphoma although its exact role in the development of this malignancy is not certain.</p>
<p>These viruses often cause asymptomatic and latent infections.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="5-family-poxviridae">5. Family Poxviridae<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#5-family-poxviridae" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>|  Size | : 300-450 nm × 170-260 nm
(Brick shaped)  |
| --- | --- |
|  Symmetry | : Unknown  |
|  Envelope | : Present  |
|  DNA | : Double stranded  |</p>
<p>Examples: All poxviruses tend to produce skin lesions. The human pathogens include variola (smallpox), vaccinia (used for small-pox vaccine) and molluscum contagiosum virus. Some animal pathogens can also infect humans e.g. cowpox and monkeypox.</p>
<p><em>Variola</em> (smallpox) is a severe disease with a high mortality rate in non-immunized persons. The virus causes skin lesions through the blood stream which later pustulate. Pustules break down and discharge the virus into environment. The main route of transmission is respiratory. Smallpox vaccine is prepared from the closely related, but much less virulent, vaccinia virus. In 1980, the World Health Organisation announced that smallpox had been eradicated world wide.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="6-family-hepadnaviridae">6. Family Hepadnaviridae<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#6-family-hepadnaviridae" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<table><thead><tr><th>Size</th><th>: 42 nm</th></tr></thead><tbody><tr><td>Symmetry</td><td>: Unknown</td></tr><tr><td>Envelope</td><td>: Present</td></tr><tr><td>DNA</td><td>: Partially double stranded</td></tr></tbody></table>
<p>The virion also contains DNA-polymerase that repairs the single stranded region to make fully double stranded molecules.</p>
<p>Example: <em>Hepatitis-B</em> virus may be transmitted from person to person by inoculation with infected blood e.g. from a contaminated hypodermic syringe and needle. Procedures like tattooing and acupuncture can also be source of infection.</p>
<p>The virus can cause hepatitis, liver cirrhosis and hepatocellular carcinoma. However, the number of silent carriers is very high. Most carriers of the virus remain healthy but a few develop chronic active hepatitis and cirrhosis, which may lead to hepatoma.</p>
<p>Specific human immunoglobulin gives passive immunity.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ii-riboviruses-rna-viruses">II. Riboviruses (RNA Viruses)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-riboviruses-rna-viruses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="1-family-picornaviridae">1. Family Picornaviridae<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-family-picornaviridae" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<table><thead><tr><th>Size</th><th>: 22-30 nm</th></tr></thead><tbody><tr><td>Symmetry</td><td>: Icosahedral</td></tr><tr><td>Envelope</td><td>: Absent</td></tr><tr><td>RNA</td><td>: Single stranded</td></tr><tr><td>Examples:</td><td></td></tr></tbody></table>
<p><em>Rhinoviruses</em>: There are more than 100 serotypes which cause the common cold.</p>
<p><em>Enteroviruses</em>: <em>Poliovirus</em>, <em>Echovirus</em> and <em>Coxsackievirus</em> belong to this genus. These viruses are ingested and multiply in the alimentary tract. They spread to the tissues and organs to which they have affinity, via the blood stream. The viruses are excreted in the faeces.</p>
<p><em>Poliovirus</em> causes poliomyelitis. It is an acute infectious disease and in its serious form affects the central nervous system. It destroys the motor neurons in the spinal cord resulting in paralysis. However, most poliovirus infections are subclinical. There are three serological types (1,2 and 3) of the virus. An oral vaccine prepared from attenuated strains of the three serotypes provides effective immunization.</p>
<p><em>Coxsackievirus</em> is a large subgroup of the enteroviruses, and is subdivided into two groups, <em>A</em> and <em>B</em>. They produce a variety of illnesses in humans.</p>
<p>Scanned by CamScanner</p>
<p>864 Medical Virology</p>
<p>mans. Herpangina, hand, foot and mouth disease, and acute haemorrhagic conjunctivitis are caused by some group A coxsackieviruses. Group B serotypes are associated with myocarditis, pericarditis and meningoencephalitis. In addition, viruses in both groups can be responsible for aseptic meningitis, respiratory and undifferentiated febrile illnesses, hepatitis and paralysis. The paralysis is usually incomplete and reversible.</p>
<p><em>Echoviruses</em> (enteric cytopathogenic human orphan viruses) have about 30 serotypes. Some of them cause aseptic meningitis, febrile illnesses with or without rash, and common cold.</p>
<p>New enteroviruses: There are newly recognised enteroviruses which are given numbers instead of names. Enterovirus type 70 is known to cause acute haemorrhagic conjunctivitis. Enterovirus type 71 can cause meningitis, encephalitis and a respiratory infection. <em>Hepatitis A virus</em> is now renamed as Enterovirus type 72.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-family-reoviridae">2. Family Reoviridae<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-family-reoviridae" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<table><thead><tr><th>Size</th><th>: 60-80 nm</th></tr></thead><tbody><tr><td>Symmetry</td><td>: Icosahedral</td></tr><tr><td>Envelope</td><td>: Absent</td></tr><tr><td>RNA</td><td>: Double stranded</td></tr></tbody></table>
<p><em>Example</em>: The family Reoviridae includes the original Reovirus genus, and rotaviruses, and other insect and plant viruses.</p>
<p><em>Reoviruses</em> cause minor febrile illnesses, diarrhoea or enteritis and are not known to cause any severe illness.</p>
<p><em>Rotaviruses</em> are a major cause of diarrhoea in infants and children. Typical symptoms include diarrhoea, fever, abdominal pain and vomiting, leading to dehydration. The name rotavirus is based on the appearance of the virus in electron microscopy. The margin of the capsid appears as the rim of a wheel surrounding radiating spokes from the inner hub-like core.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="3-family-orthomyxoviridae">3. Family Orthomyxoviridae<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-family-orthomyxoviridae" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<table><thead><tr><th>Size</th><th>: 100 nm, spherical or pleomorphic</th></tr></thead><tbody><tr><td>Symmetry</td><td>: Helical</td></tr><tr><td>---</td><td>---</td></tr><tr><td>Envelope</td><td>: Present</td></tr><tr><td>RNA</td><td>: Single stranded, segmented in 8 pieces</td></tr></tbody></table>
<p><em>Examples</em>: All orthomyxoviruses are <em>Influenza viruses</em> (types A, B and C). They have, as a part of their surface, projections that exhibit hemagglutinin and neuraminidase activity. Influenza is an acute respiratory tract infection which usually occurs in epidemics. Antigenic variation is observed very frequently in group A serotypes and less frequently in group B serotypes. Type C is antigenically stable.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="4-family-paramyxoviridae">4. Family Paramyxoviridae<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-family-paramyxoviridae" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<table><thead><tr><th>Size</th><th>: 150-300 nm, spherical or pleomorphic</th></tr></thead><tbody><tr><td>Symmetry</td><td>: Helical</td></tr><tr><td>Envelope</td><td>: Present</td></tr><tr><td>RNA</td><td>: Single stranded, non-segmented</td></tr></tbody></table>
<p><em>Examples</em>:</p>
<p><em>Mumps virus</em>: It causes an acute contagious disease characterised by a non-suppurative enlargement of one or both of the parotid glands. Other organs may also be involved.</p>
<p><em>Measles (Rubeola) virus</em>: It causes an acute, highly infectious disease characterised by a maculopapular rash and fever. It is associated with respiratory involvement.</p>
<p><em>Parainfluenza viruses</em>: Parainfluenza group of viruses can cause serious illnesses such as laryngotracheitis and croup, bronchitis, and pneumonitis, especially in the first year of life.</p>
<p><em>Respiratory Syncytial Virus (RSV)</em>: This paramyxovirus causes the most serious bronchiolitis. RSV produces a characteristic fusion of cells, syncytia, in human cell cultures.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="5-family-rhabdoviridae">5. Family Rhabdoviridae<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#5-family-rhabdoviridae" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<table><thead><tr><th>Size</th><th>: 50-95 nm × 130-390 nm, bullet shaped</th></tr></thead><tbody><tr><td>Symmetry</td><td>: Helical</td></tr></tbody></table>
<p>Scanned by CamScanner</p>
<p>Introduction 865</p>
<p>Envelope : Present
RNA : Single stranded</p>
<p>Example: Rabies Virus—It causes an acute infection of the central nervous systems that is almost always fatal. The transmission of the virus is usually through the bite of a rabid animal such as dog.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="6-family-bunyaviridae">6. Family Bunyaviridae<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#6-family-bunyaviridae" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Size : 90-120 nm
Symmetry : Helical
Envelope : Present
RNA : Single stranded, triple segmented</p>
<p>Examples: The majority of these viruses are transmitted to vertebrates by arthropodes. The name is derived from Bunyamwera, a place in Uganda from where the type species, Bunyamwera virus was first isolated. Other members include arboviruses that cause Rift valley fever and those of the Crimean-Congo haemorrhagic group.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="7-family-coronaviridae">7. Family Coronaviridae<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#7-family-coronaviridae" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Size : 80-130 nm, pleomorphic with large, clubbed projections
Symmetry : Helical
Envelope : Present
RNA : Single stranded</p>
<p>Examples: Human coronaviruses which cause common colds and gastroenteritis in infants.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="8-family-togaviridae">8. Family Togaviridae<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#8-family-togaviridae" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Size : 40-70 nm
Symmetry : Icosahedral
Envelope : Present
RNA : Single stranded</p>
<p>Examples:
Rubella Virus: It causes an acute febrile illness with rash and lymphadenopathy. It affects children and young adults. Infection in the early pregnancy may result in abnormalities of the foetus.</p>
<p>Arboviruses (arthropode-borne viruses): Many arboviruses are from the family Togaviridae. For example, Yellow fever virus which causes an acute, febrile mosquito borne illness. Severe cases may show jaundice, proteinuria and haemorrhage. Other examples of arboviruses in this family include Chikungunya, Semliki Forest and Sindbis viruses.</p>
<p>&gt; <strong>Note</strong>
&gt; Family Togaviridae is further divided into two families, Togaviridae and Flaviviridae. Hepatitis C virus is proposed to be included in the family Flaviviridae.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="9-family-arenaviridae">9. Family Arenaviridae<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#9-family-arenaviridae" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Size : 50–300 nm
Symmetry : Complex, pleomorphic
Envelope : Present
RNA : Single stranded</p>
<p>Example: Members of this family are rodent parasites which occasionally infect man, causing haemorrhagic illness, e.g. Lassa virus.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="10-family-retroviridae">10. Family Retroviridae<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#10-family-retroviridae" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Size : 80–100 nm
Symmetry : Unknown
Envelope : Present
RNA : Single stranded</p>
<p>Example: The members of this family contain a unique enzyme, reverse transcriptase, which is an RNA directed DNA polymerase. The family has many tumour producing viruses such as the Sarcoma viruses of birds and mice, and the leukaemia viruses of mice, cats, birds and humans. The human immunodeficiency viruses (HIV), the causative agent of acquired immunodeficiency syndrome (AIDS), is also included in this family.</p>
<p>Human immunodeficiency virus (HIV): Human immunodeficiency virus (HIV) is the causative agent of AIDS, acquired immunodeficiency syndrome. HIV has a cylindrical core with nucleic</p>
<p>Scanned by CamScanner</p>
<p>Medical Virology</p>
<p>acid cloned and sequenced. It is a retrovirus, but differs from other retroviruses such as human T lymphotrophic viruses (HTLV) 1 and 2. Cells bearing CD4 antigen (a major component of the viral receptor required for cell entry) are susceptible to HIV infection, but HIV has a particular affinity for the T4 helper lymphocytes. An envelope glycoprotein of the virus, gp 120, specifically binds to the CD4 molecule receptor site on the surface of the T4 lymphocytes. Once the virus is bound to the cell receptor, it can enter the cell. The viral reverse transcriptase enzyme, on entering into the infected cell, makes a DNA copy of the RNA genome (pro-viral DNA). The Pro-viral DNA can thereby bring about the destruction of the cell. The T4 lymphocyte has a central role in many immunological functions, and an infected cell can cause severe damage to the cellular immune system. Reduced immunity results in infections with many opportunistic pathogens and development of certain tumours such as Kaposi's sarcoma.</p>
<p>HIV is transmitted sexually, in blood or blood products and pre-natally. Those most at risk of acquiring HIV infection are homosexuals, injecting drug misusers and those with bisexual orientation. Others include individuals receiving unscreened blood or blood products and infants born of infected women. AIDS is an illness characterised by one or more indicator diseases. Certain diseases, when definitively diagnosed in immunocompromised individuals without the symptoms of any other cause of immune deficiency, are indicative of AIDS. Irrespective of the presence of any other cause of immune deficiency, if there is a laboratory evidence of HIV infection, certain indicator diseases that require presumptive and definitive diagnosis, are diagnostic of AIDS.</p>
<p>Acute HIV infection is usually accompanied by transient non-specific illness characterised by fever, malaise, myalgia, lymphadenopathy, pharyngitis and rash. Most of these conditions are, however, subclinical. In two to six weeks, antibodies to the core and surface proteins are usually detected by enzyme immunoassay (EIA) and confirmed by immunofluorescence or Western-blot technique. A chronic infection of AIDS that follows is asymptomatic in early stages. In some patients, a persistent generalised lymphadenopathy in the form of nodes of 1 cm or more in diameter in two or more non-contiguous extra-inguinal sites, commonly in the cervical and the axillary lymph nodes, usually develops. In the later stages of the illness, there may develop symptoms such as fever, night sweats, diarrhoea and weight loss. Patients may also suffer from 'minor' opportunistic infections such as oral candidiasis, oral hairy leucoplakia, herpes zoster, recurrent oral or anogenital herpes simplex, folliculitis, seborrhoeic dermatitis, impetigo and tinea infections. These conditions which may be signs of major opportunistic infections to come, are now collectively known as symptomatic non-AIDS; they were previously referred to as AIDS-related complex (ARC). The incubation period of HIV infection is long, lasting up to 10 years before the symptoms develop. Classical complications of AIDS are very severe.</p>
<p>Three main organs systems usually affected by AIDS are—the respiratory system, the gastrointestinal tract and the central nervous system. Most of these conditions are due to the reactivation of latent organisms in the patient or exposure to the numerous microbial flora in the environment. The overall management of AIDS involves the continuous monitoring, and treatment of these conditions with drugs that may cause some serious side effect.</p>
<p>The most common infectious agents which cause complications in AIDS patients include the following:</p>
<p>Protozoa: Pneumocystis carnii, Isospora belli, Cryptosporidium species and Toxoplasma gondii.</p>
<p>Fungi: Candida albicans, Cryptococcus neoformans, Histoplasma capsulatum, Coccidioidis immitis.</p>
<p>Bacteria: Mycobacterium tuberculosis, Mycobacterium avium-intracellulare group, Salmonella species, Listeria monocytogenes, Nocardia asteroides.</p>
<p>Viruses: Cytomegalovirus, Herpes simplex viruses, Adenovirus, Hepatitis B virus, Human papilloma virus.</p>
<p>Scanned by CamScanner</p>
<p>Introduction 867</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iii-arboviruses">III Arboviruses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-arboviruses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Arboviruses are viruses of vertebrates biologically transmitted by insect vectors. They multiply in blood sucking insect vectors such as mosquitoes and ticks, and are transmitted to vertebrates through insect bites. Grouping of arboviruses is based on ecological and epidemiological considerations and therefore, the members have diverse physical and chemical properties. The name 'arboviruses' is thus a biological rather than taxonomical concept.</p>
<p>Human pathogens among arboviruses include <em>Dengue virus</em>, <em>Yellow fever virus</em>, <em>Encephalitis viruses</em>, <em>Chikungunya virus</em>, <em>Sandfly fever virus</em> and <em>Rift valley fever virus</em>, and so on.</p>
<p>Taxonomically, arboviruses belong to families <em>Togaviridae</em>, <em>Bunyaviridae</em>, <em>Reoviridae</em> and <em>Rhabdoviridae</em>.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iv-unclassified-viruses">IV Unclassified Viruses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iv-unclassified-viruses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Some viruses have not been classified due to insufficient information to permit classification. These include some viruses causing immune complex diseases, those causing slow virus diseases and some other gastroenteritis viruses.</p>
<p>Table 1.2 shows a broad classification of medically important viruses based on their properties.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="replication-of-viruses">REPLICATION OF VIRUSES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#replication-of-viruses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Viruses need living cells to multiply. The host cell must provide the synthetic machinery, the precursors and the energy for the synthesis of viral proteins and nucleic acids. The genetic information necessary for this activity is coded in the viral nucleic acid.</p>
<p>The mode of replication of viruses was first studied with bacterial viruses called bacteriophages. Although viruses have evolved a variety of different strategies for their multiplication in the parasitized host cells, the general outline of the replication cycle is similar. It can be divided into four sequential phases, though it is a continuous process and the phases may sometimes overlap.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="phase-i-adsorption">Phase I: Adsorption<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#phase-i-adsorption" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Adsorption is the first phase of interaction between the virus and the host cells. Viruses may come in contact with the cells by random collision. Adsorption can then take place only if the host cell has specific receptors to which the virus can attach itself. Receptor molecules differ for different viruses, e.g. the picornaviruses need protein receptors while orthomyxo- and paramyxoviruses need oligosaccharide receptors. Specificity of interaction between viruses and the host cell receptor may vary. For example, the lipoprotein receptors for poliovirus are present on the cells of the central nervous system of primates only, and therefore they can infect only primates. On the other hand, togaviruses can adsorb to a wide range of hosts such as birds, mosquitoes, horses and humans.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="phase-ii-penetration-and-uncoating">Phase II: Penetration and Uncoating<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#phase-ii-penetration-and-uncoating" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>The process of penetration begins almost immediately after the adsorption of the virus to the cell surface. During penetration, the virus particle is taken up in the host cell. This is also known as <em>viropexis</em>. The process of penetration is intimately associated with the removal of the virion capsid or viral envelope from the nucleic acid or nucleoprotein core. This is known as <em>uncoating</em>.</p>
<p>The penetration and uncoating can occur in at least two different ways:</p>
<p>(i) Virus particles appear to fuse with or become engulfed by the cytoplasmic membrane and are transported directly into the cytoplasm as naked particles.</p>
<p>(ii) Some viruses may be phagocytosed and appear internally in the cell in vacuoles, which eventually break down, releasing the virus into the cytoplasm.</p>
<p>After uncoating, infectivity of the virus particle is lost till it completes its replicative cycle. This part of the growth cycle is called the eclipse period.</p>
<p>Scanned by CamScanner</p>
<p>868 Medical Virology</p>
<p>Table 1.2 Characteristics of medically important viruses</p>
<table><thead><tr><th>Group</th><th>Important Human Pathogenes</th><th>Nucleic Acid</th><th>Number of Strands</th><th>Nucleocapsid Symmetry</th><th>Enveloped Naked</th><th>Shape of Virion</th><th>Approximate Size of Virion (nm)</th></tr></thead><tbody><tr><td>Parvovirus</td><td>B-19</td><td>DNA</td><td>1</td><td>Icosahedral</td><td>Naked</td><td>Spherical</td><td>20</td></tr><tr><td>Papovavirus</td><td>Papilloma virus</td><td>DNA</td><td>2</td><td>Icosahedral</td><td>Naked</td><td>Spherical</td><td>40 – 55</td></tr><tr><td>Adenovirus</td><td>Types 1 to 8</td><td>DNA</td><td>2</td><td>Icosahedral</td><td>Naked</td><td>Spherical</td><td>80</td></tr><tr><td>Herpesvirus</td><td>Herpes simplex</td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Cytomegalovirus</td><td></td><td></td><td></td><td></td><td></td><td></td><td></td></tr><tr><td>Epstein Barr virus</td><td>DNA</td><td>2</td><td>Icosahedral</td><td>Enveloped</td><td>Roughly spherical</td><td>100</td><td></td></tr><tr><td>Poxvirus</td><td>Variola, Vaccinia</td><td>DNA</td><td>2</td><td>Complex</td><td>Enveloped</td><td>Brick shaped</td><td>300 × 240 × 100</td></tr><tr><td>Hepadnavirus</td><td>Hepatitis B</td><td>DNA</td><td>2</td><td>Unknown</td><td>Enveloped</td><td>Roughly spherical</td><td>40 – 50</td></tr><tr><td>Reovirus</td><td>Rotavirus</td><td>RNA</td><td>2</td><td>Icosahedral</td><td>Naked</td><td>Spherical</td><td>80</td></tr><tr><td>Picornavirus</td><td>Poliovirus Coxackie virus Rhinovirus</td><td>RNA</td><td>1</td><td>Icosahedral</td><td>Naked</td><td>Spherical</td><td>20 – 30</td></tr><tr><td>Togavirus</td><td>Western equine encephalitis virus</td><td>RNA</td><td>1</td><td>Icosahedral</td><td>Enveloped</td><td>Spherical</td><td>40 – 70</td></tr><tr><td>Retrovirus</td><td>HIV 1 and 2</td><td>RNA</td><td>1</td><td>Icosahedral</td><td>Enveloped</td><td>Roughly Spherical</td><td>100</td></tr><tr><td>Orthomyxovirus Influenza A, B, C</td><td>Influenza A, B, C</td><td>RNA</td><td>1</td><td>Helical</td><td>Enveloped</td><td>Roughly Spherical</td><td>80 – 120</td></tr><tr><td>Paramyxovirus</td><td>Parainfluenza, mumps, measles</td><td>RNA</td><td>1</td><td>Helical</td><td>Enveloped</td><td>Pleomorphic</td><td>100 – 300</td></tr><tr><td>Rhabdovirus</td><td>Rabies virus</td><td>RNA</td><td>1</td><td>Helical</td><td>Enveloped</td><td>Bullet shaped</td><td>175 × 70</td></tr><tr><td>Coronavirus</td><td>Coronavirus</td><td>RNA</td><td>1</td><td>Helical</td><td>Enveloped</td><td>Roughly Spherical</td><td>80 – 120</td></tr><tr><td>Arenavirus</td><td>Lymphocytic chorio-meningitis virus</td><td>RNA</td><td>1</td><td>Helical</td><td>Enveloped</td><td>Oval or Pleomorphic</td><td>100 – 300</td></tr><tr><td>Retrovirus</td><td>Human immunodeficiency virus</td><td>RNA</td><td>1</td><td>Unknown</td><td>Present</td><td>Spherical</td><td>80 – 100</td></tr></tbody></table>
<p>Scanned by CamScanner</p>
<p>Introduction 869</p>
<p>The duration of this period varies depending on individual viruses and the host. It ends with the formation of the first infectious progeny of the virus particles. Viruses are the only infectious agents which require the dissolution of the infecting agent in the process of replication.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="phase-iii-biosynthesis-of-virus-components">Phase III: Biosynthesis of Virus Components<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#phase-iii-biosynthesis-of-virus-components" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>This phase includes the synthesis of viral nucleic acid, capsid proteins, and the enzymes necessary in the various stages of virus synthesis. The proteins and regulatory enzymes which are required to shut down the normal cellular metabolism of the host cell and direct the sequential production of viral products are also synthesized during this phase. The biosynthesis may be summarised as:</p>
<p>(i) Transcription of messenger RNA (mRNA) from the viral nucleic acid.
(ii) Translation of mRNA into early proteins which are enzymes needed to initiate and maintain the synthesis of viral components and suppression of cell metabolism.
(iii) Replication of viral nucleic acid.
(iv) Synthesis of late structural proteins which are components of the viral capsid.</p>
<p>The mechanisms for transcription and nucleic acid synthesis differ in various viruses. The viral nucleic acids replicate by Watson-Crick base pairing. Some examples of mechanism of viral nucleic acid replication are:</p>
<p><strong>Viruses with double stranded DNA</strong> The double stranded DNA acts as a template for its own replication and also for transcribing into mRNA the genetic information for the synthesis of capsid proteins and enzymes.</p>
<p><strong>Viruses with single stranded DNA</strong> The DNA strand acts as a template for its complementary strand, thus forming a double stranded DNA.</p>
<p><strong>Single stranded RNA viruses</strong> In viruses such as poliovirus, the RNA can act directly as mRNA for the synthesis of viral proteins and enzymes. This RNA strand can also act as a template for the production of a complementary RNA strand. This strand in turn acts as a template for the viral RNA of new virus particles. In some other RNA viruses, e.g. <em>Influenza virus</em>, the complementary strand acts both as mRNA and as a template for RNA of new virus particles.</p>
<p><strong>Retroviruses:</strong> These viruses have a very special way of replication. The single stranded RNA is converted into an RNA:DNA hybrid by the special enzyme, reverse transcriptase. A double stranded DNA is synthesized from the RNA:DNA hybrid, which then gets integrated into the host cell genome. The double stranded DNA then transcribes synthesis of viral proteins and nucleic acids.</p>
<p>As a general rule, DNA viruses synthesize their nucleic acid in the nucleus, whereas RNA viruses produce their nucleic acid in the cytoplasm.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="phase-iv-maturation-and-release">Phase IV: Maturation and Release<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#phase-iv-maturation-and-release" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Newly synthesized viral genomes and capsid proteins assemble together to form progeny viruses. Icosahedral capsids can condense in the absence of nucleic acid, while viruses with helical symmetry need viral RNA for the formation of the capsid.</p>
<p>At this stage, the progeny of nonenveloped viruses is completely developed. There is no special mechanism for the release of nonenveloped viruses. The infected host cell eventually lyses and releases the newly formed virus particles.</p>
<p>Enveloped viruses are released by the process of budding through the cell membrane. Virus specific envelope glycoproteins are inserted into the cellular membranes. Viral nucleocapsids then bud through these modified sites, acquiring an envelope in the process. Some viruses, such as herpes simplex, bud through the nuclear membrane.</p>
<p>Enveloped viruses are not infectious until they have acquired their envelopes. Therefore, infectious progeny virions do not accumulate within the infected cell.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="pathogenesis-of-viral-infections">PATHOGENESIS OF VIRAL INFECTIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#pathogenesis-of-viral-infections" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>To cause disease, the virus must enter the host, come in contact with susceptible cells, replicate.</p>
<p>Scanned by CamScanner</p>
<p>870 Medical Virology</p>
<p>and produce cell injury. While doing so, it must overcome the defence mechanisms of the host.</p>
<p><strong>Entry and primary replication</strong> Viruses enter the host by various portals such as the respiratory or alimentary tract, through skin or by sexual contact. Some viruses replicate and produce disease at the site of entry.</p>
<p><strong>Spread of virus in the body</strong> Many viruses migrate from the site of entry via the blood stream, lymphatics or nervous tissue to reach the organ or tissue for which they have affinity. In these tissues they find susceptible cells with specific receptors on the surfaces.</p>
<p><strong>Cell damage and disease</strong> After entering the host cell, the virus may remain latent without multiplication or cause widespread tissue damage. When the damage results in the death of the cell, it is called cytocidal; when it causes cell lysis, it is called cytolytic. The damage can also manifest as cellular proliferation (e.g. <em>Molluscum contagiosum</em> which causes nodular lesions) or malignant transformation (e.g. oncogenic viruses causing malignancies).</p>
<p>The cellular damage or destruction can be due to:</p>
<p>(i) Viral nucleic acids which often inhibit protein and DNA synthesis of the host cell.
(ii) Large amounts of viral proteins accumulated in the host cell which exert toxic effects and distort its structure.
(iii) There may be a change in permeability of plasma membrane that may lead to autolysis.
(iv) Viral antigens may appear on the cell surface, e.g. hemagglutinin spikes of influenza virus appear on the host cell surface which make red cells adhere to them (Haemadsorption).
(v) Changes in the cytoplasmic membrane by the respiratory syncytial virus bring about fusion of adjacent cell membranes resulting in the formation of big clumps or syncytia.
(vi) Some viruses, e.g. measles, mumps, adenoviruses, cytomegalovirus and varicella, cause damage to the chromosome of the host cell.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="inclusion-bodies">Inclusion Bodies<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#inclusion-bodies" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>These are structures which can be demonstrated in virus-infected cells. They may be aggregations of virus particles or products of virus synthesis. Some inclusion bodies represent degenerative changes produced by the virus with the cells showing altered staining characteristics.</p>
<p>Inclusion bodies have characteristic size, shape, location and staining properties, and can be seen under the light microscope. They may be present in the cytoplasm, as in poxviruses, in the nucleus as in herpesviruses, or in both as in measles virus. They are generally acidophilic and therefore stain pink with Giemsa or Leishman stain. Inclusion bodies, called Negri bodies are seen in the cytoplasm of brain cells of animals infected with rabies virus. Molluscum contagiosum virus produces inclusion bodies as large as 20-30 µm and can be readily seen under the light microscope.</p>
<p>Scanned by CamScanner</p>
<p>Chapter 2</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="methods-of-cultivation-of-viruses">Methods of Cultivation of Viruses<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#methods-of-cultivation-of-viruses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Viruses are obligate intracellular parasites and cannot grow on inanimate media. They need living cells for replication, which can be provided by three different methods:</p>
<ol>
<li>Animal inoculation.</li>
<li>Inoculation of embryonated eggs.</li>
<li>Inoculation of organs, tissue fragments or cell monolayers.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="animal-inoculation">ANIMAL INOCULATION<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#animal-inoculation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>In the beginning of this century, inoculation of human volunteers was the only known method of cultivation of viruses and understanding viral disease. In the past few decades, however, animal inoculation has been employed for virus isolation. The laboratory animals used include monkeys, rabbits, guinea pigs, rats, hamsters and mice. The choice of animals and route of inoculation (intracerebral, intraperitoneal, subcutaneous, intradermal or intraocular) depends on the type of virus to be isolated. Handling of animals and inoculation into various routes requires special experience. In addition to virus isolation, animal inoculation can also be used to observe pathogenesis, immune response, epidemiology and oncogenesis. Growth of a virus in the inoculated animal may be indicated by visible lesions, disease or death. Sometimes serial passage into animals may be required to obtain visible evidence of viral growth.</p>
<p>Methods of animal inoculation are described in the section 'Small Laboratory Animals'.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="inoculation-of-embryonated-eggs">INOCULATION OF EMBRYONATED EGGS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#inoculation-of-embryonated-eggs" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>An embryonated egg provides an aseptic environment containing various types of tissues. A large number of viruses can be grown in the different areas of the embryonated egg (Fig. 2.1). The inoculation of eggs can be performed with relatively simple equipment.</p>
<p><img src="assets/images/image-20251219-89c0d614.jpeg" alt="img-3.jpeg"></p>
<ol>
<li>Embryo</li>
<li>Amniotic cavity</li>
<li>Yolk sac</li>
<li>Egg white</li>
<li>Allantoic cavity</li>
<li>Chorioallantoic membrane</li>
<li>Egg membrane</li>
<li>Egg shell</li>
<li>Air sac</li>
</ol>
<p>Fig. 2.1 Schematic diagram of a 10-day old egg</p>
<p>Scanned by CamScanner</p>
<p>872 Medical Virology</p>
<p>For inoculation, an 8–11 days old hen’s egg, preferably with a white shell, is used. Duck eggs can be used in some cases. After inoculation, virus replication takes 2–7 days. The contents of the egg are harvested and inspected for evidence of virus growth. Most viruses either produce morphological changes at the site of inoculation or kill the embryo; or produce haemagglutinins as evidence of growth. Egg inoculation is also useful for cultivation of chlamydiae and rickettsiae.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="steps-for-cultivation-of-viruses-in-egg">Steps for Cultivation of Viruses in Egg<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#steps-for-cultivation-of-viruses-in-egg" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li><strong>Candling</strong> Candling is the inspection of an egg over a lamp. A special candling lamp may be used. Alternatively, the egg may be held over a strong incandescent lamp. Candling the egg after 3–5 days of hatching shows whether the egg is fertile or not.</li>
</ol>
<p>Discard the infertile eggs which show a dead embryo. Candle the egg again on the tenth or eleventh day. Mark the air space with a pencil. Select a suitable site for inoculation depending on the type of virus.</p>
<ol start="2">
<li>
<p><strong>Drilling the egg shell</strong> The egg shell is disinfected by wiping with dilute alcoholic antiseptic solution. Cut a small hole at the selected site using a sterile motor driven flexible shaft or a dental handpiece. Care must be taken not to damage the egg membrane.</p>
</li>
<li>
<p><strong>Inoculation</strong> The inoculum is injected through the hole on the shell onto the desired site, using a fine needle. Inject slowly to avoid spillage of the inoculum. Seal the opening of inoculation with a sealing mixture prepared by two parts of molten paraffin (55°C) and one part of petroleum jelly.</p>
</li>
</ol>
<p>Incubate the egg at 36°C.</p>
<p><strong>Routes of inoculation</strong> The egg can be inoculated by four routes:</p>
<p>(a) <strong>Intra-amniotic inoculation</strong>: Drill a hole just above the amniotic cavity, located by candling. Gently insert the needle until the amniotic sac moves. Thrust the needle through the amniotic membrane and inject the fluid slowly. Use a small inoculum (0.1 ml). Seal the opening immediately. This route of inoculation is useful for influenza, parainfluenza and mumps viruses.</p>
<p>(b) <strong>Intra-allantoic inoculation</strong>: Select a site above the allantoic cavity by candling. Follow the same technique as for the intra-amniotic inoculation. Inoculate into the allantoic cavity. Seal the opening.</p>
<p>This is the simplest method of inoculation with a relatively large yield and is suitable for the preparation of vaccines. Influenza and paramyxoviruses grow well in the allantoic cavity.</p>
<p>(c) <strong>Yolk-sac inoculation</strong>: Determine the position of the embryo by candling. Drill a hole in the shell at the centre of the air space at the blunt end.</p>
<p>Insert a long needle and deposit the inoculum just below the centre of the egg. To ensure correct position, pull back the plunger until the yolk-sac is pulled up with it. Seal the opening of inoculation.</p>
<p>Yolk-sac inoculation is also useful for cultivation of fastidious groups of bacteria such as <em>Chlamydia</em> and <em>Rickettsia</em> species which do not grow on inanimate media.</p>
<p>(d) <strong>Chorioallantoic membrane (CAM) inoculation</strong>: Mark a small triangle at a site where there are no major blood vessels. This can be located by candling. Cut the shell along the triangle to expose the CAM.</p>
<p>Prepare a new air space at the site of inoculation by reducing the original air sac. Cut a small hole at the blunt end above the air sac. Place the egg horizontally. Apply a gentle suction with a rubber teat. A new air space develops at the top of the horizontal egg at the site of the triangular cut.</p>
<p>Fill a pipette with about 1 ml inoculum and inoculate through the gap in the CAM and the shell. Rock the egg gently to disperse the inoculum evenly over the membrane.</p>
<p>Seal both the openings by replacing the cut triangles with the sealing mixture.</p>
<ol start="4">
<li><strong>Harvesting the fluids</strong> To harvest the virus infected fluids and other structures, the shell must be opened with great care to avoid unwanted dissemination of the virus. Use of safety cabinets is</li>
</ol>
<p>Scanned by CamScanner</p>
<p>Methods of Cultivation of Viruses 873</p>
<p>recommended. Never use a drill to open infected eggs because it will create aerosols.</p>
<p>After the desired incubation period, open the air sac portion at the blunt end which is already marked during candling. Use forceps or a pair of scissors for cutting.</p>
<p>Collect the contents of the egg in a sterile petri-dish.</p>
<p>Aspirate the fluid from the inoculated area with a syringe.</p>
<p>For harvesting CAM, after removing the contents of the egg, pull out the CAM gently with tweezers. Wash in saline 2–3 times.</p>
<p>Inspect it for the presence of lesions or pocks. Figure 2.2 shows the pocks produced by a pox virus. Test the harvested fluids by direct method or other methods for the detection and identification of the virus. These methods are discussed later in the 'Diagnosis of viral infections'.</p>
<p><strong>Note.</strong> The development of tissue culture methods has largely replaced use of embryonated egg for the growth and cultivation of viruses.</p>
<p><img src="assets/images/image-20251219-c6d3fb2a.jpeg" alt="img-4.jpeg">
Fig. 2.2 Lesions produced by Vaccinia virus on chorioallantoic membrane</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="inoculation-of-organs-tissue-fragments-or-cell-monolayers">INOCULATION OF ORGANS, TISSUE FRAGMENTS OR CELL MONOLAYERS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#inoculation-of-organs-tissue-fragments-or-cell-monolayers" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The first application of tissue culture in virology was by Steinhardt et al., in 1913. They used it for the maintenance of vaccinia virus in the fragments of rabbit cornea. The major obstacle in the development of tissue culture was contamination by bacteria. It was overcome when antibiotics became available. After this, major progress was achieved by Enders and others in 1949 by growing polio virus in the tissues of non-neural origin. The virus was till then considered to be a strictly neurotropic virus. Since then, a large number of human viruses have been grown and maintained in tissue cultures.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="types-of-tissue-cultures">Types of Tissue Cultures<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types-of-tissue-cultures" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>There are three types of tissue cultures:</p>
<p>(i) <strong>Organ culture</strong> Organ cultures are essentially cultured tissue pieces in which the architecture and physiology of the tissue is retained. Such small bits of organs can be maintained in vitro for a few days. Organ cultures are necessary for the growth of some fastidious viruses, e.g. ferret trachea can be used for the isolation of some rhinoviruses and coronaviruses.</p>
<p>(ii) <strong>Explant culture</strong> This technique is particularly important for the isolation of viruses in the latent stage. The fragments of the tissue are placed in a test tube or a petri dish in a drop of plasma or fibrin clot. These 'explants' are then covered with growth medium. Adenoid tissue explant cultures were used for the isolation of adenoviruses.</p>
<p>(iii) <strong>Cell culture</strong> This is the most widely used technique for growing viruses. By the action of proteolytic enzymes such as trypsin, a tissue is dissociated into its component cells. After washing, cells are suspended in growth medium containing essential amino acids, vitamins, salts, glucose and a buffer. Serum such as foetal calf or newborn bovine serum is added as supplement. Antibiotics are also added to prevent bacterial contamination. A change in pH is indicated by phenol red incorporated in the medium. The cell suspension in this growth medium is dispensed in flasks or tubes. The cells adhere to the surface of the flasks. When incubated under appropriate conditions, they divide and redivide to form a confluent sheet of cells in a single layer. This is known as monolayer. It is</p>
<p>Scanned by CamScanner</p>
<p>Medical Virology</p>
<p>achieved by a mechanism known as contact inhibition. This occurs when cells come in contact with surrounding cells which inhibits further multiplication. Formation of a monolayer to cover the surface of the culture vessel usually takes three to seven days depending on the type of cells used.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="types-of-cell-culture">Types of Cell Culture<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#types-of-cell-culture" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Three types of cell cultures are used in virology depending on their origin, chromosomal characters and the number of generations they can be maintained.</p>
<p><strong>Primary cell cultures</strong> These are prepared from an organ which is minced into small pieces, treated with an enzyme and then used for the preparation of a monolayer. They are capable of only limited growth in culture. Only a few serial passages can be made from such primary cell cultures (Fig. 2.3).</p>
<p><img src="assets/images/image-20251219-613b354c.jpeg" alt="img-5.jpeg"></p>
<ol>
<li>Cells are obtained from an organ</li>
<li>Pieces of organ are treated with trypsin</li>
<li>The trypsinized cells are grown in the form of monolayers in a nutrient medium in cell culture flasks.</li>
</ol>
<p>Fig. 2.3 Primary cell-line</p>
<p>The advantage of using a primary cell culture is that, if sufficient animal organs are available, a large number of cultures can be prepared. The disadvantage is that primary cell cultures can contain latent viruses in the donor animal. The commonly used primary cell cultures are monkey kidney, human embryonic kidney, human aninion and chick embryo cell cultures. Primary cell cultures are useful for isolation of viruses such as enteroviruses, myxo- and paramyxoviruses. They are used for large scale production of vaccines.</p>
<p><strong>Diploid cell cultures (semicontinuous cell cultures or cell strains)</strong> These cultures mostly consist of a single type of cells which may undergo 30–50 passages before ‘senescence’ or death of the culture. The human embryonic lung or kidney fibroblasts make excellent diploid cell strains, e.g. MRC5, W138 are fibroblast strains.</p>
<p>Diploid cultures are maintained by creating a pool of frozen cells stored in liquid nitrogen. Serial passages of primary cell culture are made and large portions of the initial 8–10 passages are stored in liquid nitrogen. Routine cultures may be started later, for example, from the fifteenth passage and the same line can be used up to about the thirtieth passage. When the diploid cell strains start dying, the subcultures can be restarted from the frozen portions (Fig. 2.4). In this way, the cells from the same source can be used for many years giving constant results.</p>
<p><img src="assets/images/image-20251219-62b49fd1.jpeg" alt="img-6.jpeg"></p>
<ol>
<li>Cells collected from an organ</li>
<li>Primary culture</li>
<li>Subsequent passages</li>
<li>Some cells stored in liquid nitrogen from each passage.</li>
<li>Liquid nitrogen</li>
<li>Cell lines for laboratory use</li>
<li>When cells from (6) start dying, fresh passages can be started from liquid nitrogen.</li>
</ol>
<p>Fig. 2.4 Diploid cell-line</p>
<p>Scanned by CamScanner</p>
<p>Methods of Cultivation of Viruses 875</p>
<p>Diploid cell strains are used for selective isolation of some viruses, and for preparation of vaccines. These include herpes simplex, cytomegalovirus, varicellazoster and rhinovirus.</p>
<p><strong>Continuous cell-lines</strong> As the name suggests, these cells may be serially subcultured indefinitely (Fig. 2.5). The continuous cell lines have a malignant character, and the number of chromosomes is different from that of the original host. The cells are described as heteroploid. These cells have a very fast growth rate and contact inhibition is absent.</p>
<p><img src="assets/images/image-20251219-713f48a3.jpeg" alt="img-7.jpeg"></p>
<ol>
<li>Continuous passage of cells every two weeks.</li>
<li>Cell cultures are split for cell lines for routine laboratory use.</li>
<li>Cells are stored in liquid nitrogen at regular intervals as a stock for future use.</li>
</ol>
<p>Fig. 2.5 Continuous cell lines</p>
<p>The continuous cell lines commonly used in the laboratory are HeLa (human cervical cancer), HEp2 (human epithelial), BHK21 (baby hamster kidney), RK13 (rabbit kidney) and Vero (African green monkey kidney). HeLa, HEp2 and Vero cells are used for the cultivation of poliovirus, coxsackie virus, adenovirus and herpes simplex virus. RK13 and BHK21 can be valuable for the isolation and propagation of rubella virus. However, the continuous cell lines cannot be used for the preparation of vaccines because vaccines grown in cancer cells are not considered to be safe.</p>
<p>Table 2.1 shows the types of cell cultures commonly used.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="tissue-culture-media">Tissue Culture Media<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#tissue-culture-media" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Cells need culture media for their growth. A large number of tissue culture media have been devised for the growth of cells in culture. Some of them are made for special purposes. Others are made for general use. These media contain various concentrations of amino acids, vitamins, growth factors and inorganic salts. Carbohydrates such as glucose, fructose or galactose are added with glutamine as a source of carbon for metabolism of cells. Such media are also available commercially. For example, MEM (minimum essential medium) by Eagle.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="conditions-for-growth-and-maintenance-of-cell-cultures">Conditions for Growth and Maintenance of Cell Cultures<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#conditions-for-growth-and-maintenance-of-cell-cultures" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Conditions required for cell cultures vary depending upon the type of cells used. Essential vitamins</p>
<p>Table 2.1 Types of cell lines</p>
<table><thead><tr><th>Type of Culture</th><th>Characteristics</th><th>Examples</th><th>Primary Use</th></tr></thead><tbody><tr><td>Primary</td><td>Diploid; mixed cell types; 1 or 2 passages</td><td>Primary monkey kidney</td><td>Influenza; parainfluenza; some enteroviruses</td></tr><tr><td>Cell lines</td><td>Diploid; fibroblasts; limited passage (&lt;50–70)</td><td>Human diploid fibroblast (W1-38, MRC-5 or HEL)</td><td>Herpes simplex; cytomegalovirus; varicella-zoster; rhinovirus</td></tr><tr><td>Established cell lines</td><td>Heteroploid; continuous passage in vitro</td><td>HeLa; HEp-2</td><td>Adenovirus; RSV</td></tr></tbody></table>
<p>Scanned by CamScanner</p>
<p>Medical Virology</p>
<p>and amino acids are required by all the cell lines. Most components are well preserved at 4°C except for L-glutamine, which should be added freshly at the time of use.</p>
<p>MEM is supplemented with about 10% serum to enhance initial growth. After the monolayer reaches confluence, the serum concentration may be reduced to 0.5% for maintenance of the monolayer. The serum used must be free from infectious agents such as mycoplasma and from antibodies to viruses. Foetal calf serum is most commonly used. Some cell lines need higher concentration of nutrients than others. MEM is the commonest culture medium for cell lines. It contains the following:</p>
<p>Base: Balanced salt solution.</p>
<p>L-amino acids: Arginine, histidine, lysine, tryptophane, phenylalanine, theonine, leucine, valine, isoleucine, methionine, tyrosine and cystine.</p>
<p>L-glutamine is added just before use.</p>
<p>Vitamins: Nicotinamide, pyridoxal, thiamine, pantothenic acid, choline, i-inositol, riboflavin, biotin and folic acid.</p>
<p>Antibiotics: Penicillin (100u/ml), Streptomycin (200μg/ml) and Gentamicin (50μg/ml) are freshly added just before use.</p>
<p>Foetal calf serum: 10% for growth medium, 0.5% for maintenance medium. Add just before use.</p>
<p><strong>Note</strong> The serum, antibiotics and l-glutamine need to be stored at -20°C, others are stable at 4°C.</p>
<p>The optimum temperature for cell growth is 35–37°C, but may be lowered to 33°C for the isolation of viruses such as rhinoviruses or myxoviruses. The incubation should be in the atmosphere of 5–10% carbon dioxide. The pH of the medium should be 7.2 to 7.4. Phenol red is often added to the medium to indicate changes in pH.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="contamination-of-cell-cultures">Contamination of Cell Cultures<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#contamination-of-cell-cultures" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Cell cultures may be contaminated with cells from another cell-line, bacteria especially mycoplasmas, viruses or fungi. Sources of contamination can be the environment, improper sterilisation of media and other reagents, or poor aseptic techniques.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="cell-contamination-of-cell-cultures">Cell contamination of cell cultures<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#cell-contamination-of-cell-cultures" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A mixed monolayer may result when cell cultures are contaminated with cells from another cell-line. This contamination can be detected by microscopic examination of the cell layer. Cell contamination may be avoided by taking the following precautions:</p>
<p>(i) One should never work with more than one cell strain at a time in a safety cabinet.
(ii) Periodic cell identity checks should be done.
(iii) Sterile pipettes should be used only once.
(iv) Media and reagents should be dispensed and kept frozen in aliquots sufficient only for one task.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="microbial-contamination-of-cell-cultures">Microbial contamination of cell cultures<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#microbial-contamination-of-cell-cultures" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Accidental microbial contamination can be minimized by taking precautions:</p>
<p>(i) Media, serum and other solutions should be thoroughly tested for sterility before use.
(ii) The use of laminar flow cabinets will minimize contamination from air.
(iii) Uncontaminated frozen cell-stocks should be always available for replacement.
(iv) Contaminated cultures should be immediately discarded and replaced with new stock cultures.</p>
<p><strong>Note</strong> Treatment of contaminated cultures may be attempted only if the contaminant is isolated and identified; and sensitivity test results are obtained. Usually the contamination is considerable by the time it is detected. Generally it is time consuming and impossible to eliminate. However, identification of the contaminant may help in indicating the source of contamination and further precautions can then be taken accordingly.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="materials-for-cell-culture-techniques">Materials for Cell Culture Techniques<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#materials-for-cell-culture-techniques" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="glassware">Glassware<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#glassware" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Borosilicate glassware which can withstand strong solvents and autoclaving is suitable for cell cultures. While cleaning, residual cell</p>
<p>Scanned by CamScanner</p>
<p>Methods of Cultivation of Viruses 877</p>
<p>fragments must be removed from the used cell culture tubes. This is easily achieved if the cell culture tubes are immersed in hypochlorite solution before autoclaving. This is followed by mechanical brushing and several rinses in tap water and two rinses in purified water.</p>
<p>Culture containers Glass and disposable polystyrene plastic containers are routinely used for cell cultures. Large surfaces of cells are produced in a pyrex glass Roux flask. Glass flasks can be readily cleaned and offer good support for most cell lines. Small disposable tissue culture flasks made of polystyrene (Fig. 2.6) are fit for propagating small stocks of viruses.</p>
<p><img src="assets/images/image-20251219-9100f282.jpeg" alt="img-8.jpeg">
Fig. 2.6 Disposable plastic tissue culture flasks</p>
<p>Large volumes of cells can be obtained by growing monolayer cultures in cylindrical roller bottles. These bottles, filled with dispersed cells, are placed horizontally in roller drums and slowly rotated. The cells adhere to the inner surface of the bottles and multiply to form monolayers.</p>
<p>Purified water A supply of highly purified water is mandatory for all the solutions coming into contact with the cells. The use of de-ionized single or double distilled water is acceptable.</p>
<p>Membrane filters Cellulose membrane filters are used for the sterilization of culture media and other solutions. The pore sizes should vary from 8 µm to 0.025 µm.</p>
<p>Laminar flow cabinets The laminar flow cabinets minimize the risk of contaminating the cell cultures with airborne microbes. These cabinets have high efficiency particulate air (HEPA) filters which sterilize the air flowing through the cabinet. Such cabinets protect the operator from potential pathogens and minimize the number of organisms in the working area.</p>
<p>Incubators A temperature range of 35–37°C is optimum for the growth of cell cultures. Humidified incubators with 5% CO₂ in air are ideal to make up for the loss of water and CO₂ from cultures during incubation.</p>
<p>Microscopes Direct viewing of cells cultured in plastic or glass bottles is possible with an inverted microscope at a magnification of 40X.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="preparation-of-primary-cell-culture">PREPARATION OF PRIMARY CELL CULTURE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#preparation-of-primary-cell-culture" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="reagents">Reagents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#reagents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Dulbecco's phosphate buffered saline (PBS)</li>
</ol>
<table><thead><tr><th>Solution A</th><th></th></tr></thead><tbody><tr><td>Sodium chloride</td><td>8.0 g</td></tr><tr><td>Potassium chloride</td><td>0.2 g</td></tr><tr><td>Disodium hydrogen phosphate (Na₂HPO₄)</td><td>1.15 g</td></tr><tr><td>Potassium dihydrogen phosphate (KH₂PO₄)</td><td>0.2 g</td></tr><tr><td>Distilled water</td><td>1000 ml</td></tr></tbody></table>
<p>Add a few drops of 1% phenol red (see below) until the solution is pale pink (pH 7.3). Distribute in 100 ml amounts and autoclave for 20 minutes at 115°C. Store at 4°C.</p>
<table><thead><tr><th>Solution B</th><th></th></tr></thead><tbody><tr><td>Potassium chloride</td><td>0.2 g</td></tr><tr><td>Calcium chloride (CaCl₂)</td><td>2.0 g</td></tr><tr><td>Magnesium chloride (MgCl₂·6H₂O)</td><td>2.0 g</td></tr><tr><td>Distilled water</td><td>100 ml</td></tr></tbody></table>
<p>Dispense in 2.5 ml amounts and autoclave at 115°C for 20 minutes.</p>
<p>Scanned by CamScanner</p>
<p>Medical Virology</p>
<p>Complete PBS</p>
<p>Add 0.5 ml solution B to 100 ml solution A (pH 7.4).</p>
<p>Phenol Red (1%)</p>
<p>Phenol red 10.0 g
Sodium hydroxide (0.1 mol/L) 325 ml
Distilled water upto 1000 ml
Distribute in 20 ml amounts.
Autoclave at 115°C for 20 min.</p>
<p>Trypsin solution (0.25% w/v)</p>
<p>Trypsin (1:250) 2.5 g
PBS solution A 1000 ml</p>
<p>Stir the solution vigorously for 4–5 hours at room temperature. Adjust the pH to 7.4. Sterilize by membrane filtration.</p>
<p>Check the sterility by inoculating a small portion in glucose broth.</p>
<p><strong>Note</strong>: Tablets of PBS and various strengths of trypsin solution are commercially available.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="technique">Technique<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#technique" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Prepare a mixture of sterile phosphate buffered saline (PBS) and antibiotics (penicillin 100 units/ml and gentamicin 50 µg/ml) in a collection bottle.</li>
<li>Place the appropriate tissue in the above fluid mixture. For example, lung or kidney tissue to prepare primary human fibroblast monolayer.</li>
<li>Chop and mince the tissues into small pieces with sterile scissors and wash at least three times with sterile PBS-antibiotics solution.</li>
<li>Warm about 50 ml of 0.25% (w/v) trypsin solution to 37°C. Transfer the minced tissue to it.</li>
<li>Stir it moderately on a magnetic stirrer at 37°C for 2½ hours. During this period, stop the stirrer at one hour interval, allow the non-dispersed tissue to settle, and collect the supernatant fluid in a separate container. Add fresh, prewarmed trypsin solution and repeat the process.</li>
<li>Centrifuge the supernatant fluid after each collection at 200 g for five minutes. Resuspend in 2–3 ml of chilled medium containing 15% (v/v) foetal calf serum. The serum inhibits further action of trypsin.</li>
<li>Pool all the cells collected above. Wash the cells twice in PBS. Dilute the suspension in the growth medium to contain 2 × 10⁵ cells/ml (see below). Dispense into suitable culture vessels.</li>
<li>Incubate at 37°C in 5–10% CO₂ till the cells spread to form a monolayer.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="counting-viable-cells-in-the-suspension">Counting Viable Cells in the Suspension<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#counting-viable-cells-in-the-suspension" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>After trypsinization, washing and dilution, dispersed viable cells are counted using a counting chamber such as the Neubauer. Trypan blue differentiates the dead cells, which take up the stain, from viable cells, which are not stained.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="reagent">Reagent<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#reagent" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="trypan-blue-solution">Trypan blue solution<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#trypan-blue-solution" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Trypan blue (vital stain, C.Z. 23850) 0.40 g
Sodium chloride (NaCl) 0.81 g
Dipotassium hydrogen phosphate (K₂HPO₄) 0.06 g
Methyl p-hydroxybenzoate 0.05 g
Water 900 ml</p>
<p>Heat the mixture till it boils, cool and adjust the pH to 7.2–7.3 using 1 mol/L NaOH (approx. 8 drops). Adjust the volume to 1000 ml with distilled water.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="technique">Technique<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#technique" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Dilute 0.1 ml of dispersed cell suspension with 0.9 ml of the trypan blue solution in a test tube.</li>
<li>After five minutes, mix well and fill both the sides of a counting chamber.</li>
<li>Count the number of viable (unstained) cells in four large corner squares and the central square of each side (10 squares).</li>
<li>Calculate the number of cells per ml</li>
</ol>
<p>Area of each square = 1 mm²
Depth of the chamber = 0.1 mm
Therefore, volume of fluid in each square = 0.1 cu.mm
The sample volume used for counting = 10 × 0.1 = 1 cu.mm</p>
<p>Scanned by CamScanner</p>
<p>Methods of Cultivation of Viruses 879</p>
<p>Therefore the cell concentration/ml = number of cells counted × 10 (dilution factor) × 1000</p>
<ol start="5">
<li>To determine the viability, count both the stained and unstained cells separately in a given area. It is advisable to count at least 100 cells.</li>
</ol>
<p>The percentage of viable cells</p>
<div class="math math-display"><span class="katex-display"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML" display="block"><semantics><mrow><mfrac><mtext>Number&nbsp;of&nbsp;unstained&nbsp;cells</mtext><mrow><mtext>Number&nbsp;of&nbsp;both&nbsp;stained</mtext><mo>+</mo><mtext>unstained&nbsp;cells</mtext></mrow></mfrac><mo>×</mo><mn>100</mn></mrow><annotation encoding="application/x-tex">\frac{\text{Number of unstained cells}}{\text{Number of both stained} + \text{unstained cells}} \times 100</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 2.1408em; vertical-align: -0.7693em;"></span><span class="mord"><span class="mopen nulldelimiter"></span><span class="mfrac"><span class="vlist-t vlist-t2"><span class="vlist-r"><span class="vlist" style="height: 1.3714em;"><span style="top: -2.314em;"><span class="pstrut" style="height: 3em;"></span><span class="mord"><span class="mord text"><span class="mord">Number&nbsp;of&nbsp;both&nbsp;stained</span></span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">+</span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mord text"><span class="mord">unstained&nbsp;cells</span></span></span></span><span style="top: -3.23em;"><span class="pstrut" style="height: 3em;"></span><span class="frac-line" style="border-bottom-width: 0.04em;"></span></span><span style="top: -3.677em;"><span class="pstrut" style="height: 3em;"></span><span class="mord"><span class="mord text"><span class="mord">Number&nbsp;of&nbsp;unstained&nbsp;cells</span></span></span></span></span><span class="vlist-s">​</span></span><span class="vlist-r"><span class="vlist" style="height: 0.7693em;"><span></span></span></span></span></span><span class="mclose nulldelimiter"></span></span><span class="mspace" style="margin-right: 0.2222em;"></span><span class="mbin">×</span><span class="mspace" style="margin-right: 0.2222em;"></span></span><span class="base"><span class="strut" style="height: 0.6444em;"></span><span class="mord">100</span></span></span></span></span></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="subculture-of-continuous-or-semicontinuous-cell-lines-passaging">Subculture of Continuous or Semicontinuous Cell-lines (Passaging)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#subculture-of-continuous-or-semicontinuous-cell-lines-passaging" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>After the monolayer in a culture vessel has become confluent, and before the cell death begins, the continuous and semi-continuous cell lines should be subcultured into fresh culture vessels.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="reagent">Reagent<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#reagent" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="trypsin-edta-solution">Trypsin-EDTA Solution<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#trypsin-edta-solution" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>EDTA (sodium ethylenediamine tetra-acetic acid) 0.2 g
Trypsin (1:250) 1.0 g
PBS solution A 1000 ml</p>
<p>Stir the solution vigorously at room temperature for 3–5 hours. Adjust the pH to 7.4. Sterilize by membrane filtration.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="trypsinisation-technique">Trypsinisation technique<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#trypsinisation-technique" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Before trypsinizing any cell-line, ensure that it is healthy and confluent.</p>
<ol>
<li>Pour off the culture medium aseptically from the culture vessel containing cells.</li>
<li>Wash the cell layer twice with PBS (Solution A) to remove traces of medium.</li>
<li>Add sufficient trypsin-EDTA solution so that it covers the monolayer. Leave for 30–60 seconds at room temperature. The cell sheet appears opaque. At this stage, the cells appear rounded, but not detached, under the inverted microscope.</li>
<li>Remove the excess of trypsin-EDTA solution and place the cells at 36°C for 2–3 minutes or until the cell sheet is detached from the surface of the culture vessel.</li>
</ol>
<p>&gt; <strong>Note</strong>
&gt; The optimum time for step 3 and 4 may vary with different cell lines and should be determined for individual cell-line.</p>
<ol start="5">
<li>Stop the action of trypsin by adding 10 ml of the growth medium. Rinse vigorously several times with a 10 ml pipette to separate and suspend the cells.</li>
<li>Dilute a small sample of the suspension with trypan blue, count the cells, and dilute, if necessary. Semicontinuous cultures are generally transferred from one culture container into two containers of the same volume as the original (1 to 2 split). Continuous cultures can be split 1 to 6 or even 1 to 10.</li>
<li>After counting, the cells may be seeded into culture tubes, microtitre plates, culture flasks, or other culture vessels.</li>
<li>Add appropriate volume of the growth medium to each seeded culture vessel e.g. about 15 ml for the 25 sq. cm. surface flask, 50 ml for the 75 sq. cm. surface flask etc.</li>
<li>Incubate the cells at 37°C at 5–10% CO₂.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="freezing-cells-for-storage">Freezing Cells for Storage<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#freezing-cells-for-storage" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Trypsinize subconfluent, actively growing cells.</li>
<li>Resuspend the cells in the growth medium and dilute to a desired concentration of 2–8 × 10⁶ viable cells/ml.</li>
<li>Add glycerol to a final concentration of 10% (v/v).</li>
<li>Label sterile ampoules or disposable bottles with the name of the cell line and the number of subculture (passage) (Fig. 2.4 and 2.5). Dispense the cell suspension in aliquots of 1–2 ml. Place the ampoules in a thick walled polystyrene box. Seal the box and place it in a deep freezer at –70°C for about 2–18 hours.</li>
<li>At –70°C, the cell container may be placed in the vapour phase of liquid nitrogen for a long time storage. The cells should not be</li>
</ol>
<p>Scanned by CamScanner</p>
<p>880 Medical Virology</p>
<p>allowed to thaw before placing them into the liquid nitrogen from the freezer.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="revival-of-frozen-cells">Revival of Frozen Cells<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#revival-of-frozen-cells" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Remove the ampoule or bijoux bottle from the liquid nitrogen only after it has been in the liquid nitrogen for at least 18 hours. Immediately thaw the contents by agitation at 37°C in a water bath.</li>
<li>Open the cell suspension container aseptically and put two drops of the suspension in nutrient broth to check for sterility. Incubate at 37°C for 24 hours.</li>
<li>Add the remaining suspension to 15 ml of a suitable growth medium.</li>
<li>Remove 2 ml of the mixture of cells and growth medium and place it in a tube or petri dish containing a coverslip for mycoplasma screening.</li>
<li>Put the remainder in a small (25 cm²) culture flask.</li>
<li>Incubate overnight and note the percentage of viable cells. Decant the growth medium in the flask and replace it with fresh growth medium. Continue incubation until the cell layer is confluent.</li>
<li>Check the sterility tube and mycoplasma culture. Record the number of cells recovered from the frozen cells.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="detection-of-mycoplasma-in-cell-culture-using-hoechst-stain-kit">Detection of Mycoplasma in Cell Culture Using Hoechst Stain Kit<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#detection-of-mycoplasma-in-cell-culture-using-hoechst-stain-kit" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p><strong>Principle</strong> This is a DNA fluorochrome staining technique used for the detection of contamination of cell cultures. Cytoplasmic DNA of contaminants such as mycoplasma fluoresces prominently when viewed under fluorescent microscope. DNA fluorochromes such as DAPI or quinacrine mustard can be used.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="reagents">Reagents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#reagents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<table><thead><tr><th>1. Carnoy's fluid</th><th></th></tr></thead><tbody><tr><td>Glacial acetic acid</td><td>10 ml</td></tr><tr><td>Methanol</td><td>30 ml</td></tr></tbody></table>
<ol start="2">
<li>DNA fluorochrome stain</li>
</ol>
<ul>
<li>Hoechst stain No. 33258 500 µg</li>
<li>Merthiolate 100 mg</li>
<li>PBS 1000 ml</li>
</ul>
<p><strong>Working solution:</strong> Dilute the stain 1:10 in PBS.</p>
<ol start="3">
<li>Mounting medium</li>
</ol>
<ul>
<li>Citric acid 1.0507 g</li>
<li>Disodium hydrogen phosphate 1.4196 g</li>
<li>Glycerol 50 ml</li>
<li>Distilled water 50 ml</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="method">Method<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#method" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<ol>
<li>Remove 2 ml of the cell suspension in growth medium to be checked for mycoplasma and place it in a petri dish containing a coverslip.</li>
<li>Incubate at 36°C till the cell layer is semi confluent on the coverslip.</li>
<li>Add an equal volume of Carnoy's fixative and leave for two minutes.</li>
<li>Decant or aspirate the fluid and replace Carnoy's fixative for five minutes.</li>
<li>Repeat step 4.</li>
<li>Air-dry the coverslip for 30 minutes.</li>
<li>Add 1.0 ml of the working solution of the stain and leave for 10–30 minutes at room temperature.</li>
<li>Wash the coverslip three times in distilled water.</li>
<li>Allow the coverslip to air-dry.</li>
<li>Mount in the mountant and examine under fluorescent microscope.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="results">Results<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#results" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Nuclei of the cells in the monolayer exhibit fluorescence under the microscope. Mycoplasma, if present appear as tiny fluorescent dots around the nucleus either singly or in groups. They have a uniform size ranging from 0.1–0.3 µm in diameter and may be pleomorphic, ranging from spherical to filamentous forms.</p>
<p>&gt; <strong>Note</strong>: Other bacterial contaminants or yeasts show typical morphological and cultural characteristics.</p>
<p>Scanned by CamScanner</p>
<p>Chapter 3</p>
<p>Diagnosis of Viral Disease</p>
<p>In recent years laboratory diagnosis of viral diseases has undergone a rapid change and plays an important role in overall patient management. Early diagnosis is very important because many antiviral drugs are now available for treatment. This chapter deals with the collection and transport of specimens, and diagnostic methods.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="collection-of-specimens-for-virology">COLLECTION OF SPECIMENS FOR VIROLOGY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#collection-of-specimens-for-virology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Specimens should be collected during the acute stage of illness when viruses are shed in large numbers. The appropriate specimens collected for various viral infections are listed in Table 3.1. Specimens such as swabs or tissues should not be allowed to dry before reaching the laboratory. Such specimens should be placed in about 3–4ml of a viral transport medium (VTM) so that the viruses do not die due to dehydration. The VTM has a buffering system to maintain the pH between 7.2 and 7.4, a low concentration of protective proteins and antibiotics to inhibit bacterial and fungal contaminants. Various types of VTM are commercially available. A simple VTM can be prepared as follows:</p>
<p>Viral transport medium (VTM)
Hank's balanced salt solution : 100 ml
Foetal bovine serum : 2 ml</p>
<p>Gentamicin : 10 mg
Amphoterin B : 50 μg</p>
<p>Commonly used specimens include</p>
<ol>
<li>
<p>Throat swab: Swab the tonsillar area and the posterior wall of the pharynx with a cotton tipped sterile swab. Place it in 3–4ml of VTM and send it to the laboratory immediately.</p>
</li>
<li>
<p>Respiratory aspiration: Collect the respiratory secretions into a plastic disposable suction aspirator using a fine gauge rubber catheter. In babies, pass it through the nose, and in adults through the posterior pharynx.</p>
</li>
<li>
<p>Nasal washings: Instill about 5 ml saline into each nostril and collect into a screw-capped bottle. Alternatively, a cotton swab may be used. It should be left in the nostril for 15–20 seconds and rotated firmly to collect the newly formed secretions.</p>
</li>
<li>
<p>Mucous membrane swabs: Swab the mouth, lips or genital areas and put into VTM.</p>
</li>
<li>
<p>Conjunctival swabs: Collect these swabs using dry cotton swabs. Roll a dry cotton swab gently along the lower conjunctival surface. Collect into VTM.</p>
</li>
<li>
<p>Vesicle fluid: Aspirate several vesicles using a tuberculin syringe and a 15 gauge needle. If possible, choose fresh, plump vesicles. Send the vesicle fluid in a sterile container to the laboratory.</p>
</li>
<li>
<p>Cerebrospinal, pericardial and pleural fluid: Place about 1 ml of fluid in a dry, sterile container.</p>
</li>
</ol>
<p>Scanned by CamScanner</p>
<p>882 Medical Virology</p>
<ol start="8">
<li>
<p>Saliva, urine, stool: These specimens should be collected in sterile containers. Rectal swab may be used if stool cannot be obtained.</p>
</li>
<li>
<p>Tissue: It should be collected from an appropriate part of the organ, placed in a sterile container containing 3–4 ml of VTM and kept at 4°C until it reaches the virology laboratory.</p>
</li>
<li>
<p>Blood: Collect 10 ml of blood in a sterile container containing heparin, EDTA or citrate. For serology, collect blood in a plain sterile tube.</p>
</li>
<li>
<p>Postmortem specimens: These should be collected from the suspected sites of disease and transported to the laboratory as soon as possible.</p>
</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="transport-and-storage-of-specimens-for-virology">TRANSPORT AND STORAGE OF SPECIMENS FOR VIROLOGY<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#transport-and-storage-of-specimens-for-virology" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Specimens for viral diagnosis must be considered infectious and should be handled with great care. Regulations for postage and transport must be fully observed. Within the laboratory, the specimens should be handled only in safety cabinets without releasing aerosols. Every virus isolation specimen should be treated as urgent and transported to the virus laboratory without delay. If it is unavoidable to wait for a transport, the specimen in a transport medium should be kept at 4°C, but not at 0°C or in an ice-box.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="table-3-1-specimens-for-diagnosis-of-viral-infections">Table 3.1 Specimens for diagnosis of viral infections<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#table-3-1-specimens-for-diagnosis-of-viral-infections" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<table><thead><tr><th>Syndromes</th><th>Probable viral agents</th><th>Specimens</th></tr></thead><tbody><tr><td>Respiratory syndrome</td><td>Adenoviruses, Enteroviruses, Influenza virus, Parainfluenza virus, Respiratory syncytial virus (RSV), Rhinoviruses</td><td>Throat swab, nasopharyngeal aspirate (NPA)</td></tr><tr><td>Dermatological and mucous membrane disease</td><td></td><td></td></tr><tr><td>(i) Vesicular (hand-foot and mouth syndrome)</td><td>Enterovirus, Herpes simplex, Varicella-zoster</td><td>Stool, NPA, vesicle fluid or scraping</td></tr><tr><td>(ii) Exanthematous</td><td>Enterovirus, Measles, Rubella, Parvovirus</td><td>Stool, NPA, Serum</td></tr><tr><td>CNS infections</td><td>Arboviruses, Enteroviruses, Herpes simplex, Mumps virus</td><td>Stool, CSF, NPA</td></tr><tr><td>Gastrointestinal</td><td>Adenoviruses, Rotavirus</td><td>Stool</td></tr><tr><td>Congenital and perinatal</td><td>Cytomegalovirus, Enterovirus, Herpes simplex virus</td><td>Urine, NPA, CSF, blood</td></tr><tr><td>Eye syndrome</td><td>Adenoviruses, Herpes simplex virus, Vaccinia virus, Varicella-zoster virus, (Chlamydiae)</td><td>Conjunctival swab or scraping, NPA</td></tr><tr><td>CMV infection</td><td>Cytomegalovirus (CMV)</td><td>Urine, NPA, blood</td></tr><tr><td>Myocarditis, pericarditis</td><td>Coxsackie B</td><td>Stool, NPA, pericardial fluid</td></tr><tr><td>Hepatitis</td><td>Hepatitis A, B, C, D and E viruses, CMV/Epstein Barr virus</td><td>Stool, serum (except for A and E) Serum</td></tr></tbody></table>
<p>Scanned by CamScanner</p>
<p>Diagnosis of Viral Disease 883</p>
<p>Care must be taken during transport and storage of specimens that the virus in the specimen should survive. Factors which can destroy viruses are dehydration, heat, freezing at temperatures near 0°C, sudden pH changes, oxidising agents and ultraviolet light.</p>
<p>Aspirates, fluids and tissues should be sent to the laboratory in a sterile, leak-proof container. Swabs should never be left to dry and should be placed in VTM immediately.</p>
<p>When received in the laboratory, the specimens should be refrigerated (4°C) until they are inoculated into cell cultures. A specimen may be kept at 4°C for up to 96 hours. If the delay is longer, it should be stored at –70°C. Specimens expected to contain viruses such as enteroviruses, adenoviruses, or pox viruses should be stored at –20°C.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="diagnostic-methods">DIAGNOSTIC METHODS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#diagnostic-methods" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>There are several methods by which viral disease can be diagnosed in a clinical laboratory. These laboratory procedures can be divided into three categories:</p>
<p>I. Direct methods Direct methods of viral diagnosis are based on</p>
<p>(i) Detection of virus particles, viral antigen or viral nucleic acid in clinical specimens
(ii) Detection of characteristic changes in the tissues or cells at the site of infection.</p>
<p>II. Isolation and identification of the causative agent Isolation of the infecting virus from appropriate specimens and its identification can establish diagnosis.</p>
<p>III. Serological diagnosis Detection of specific viral antibodies and their quantitation at various stages of the disease is an important tool for the diagnosis of many viral diseases.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="direct-methods-for-detection-of-viruses">DIRECT METHODS FOR DETECTION OF VIRUSES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#direct-methods-for-detection-of-viruses" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Direct detection of viruses, including their antigens or nucleic acids in clinical specimens provides rapid diagnosis of some viral diseases, and can be done in various ways:</p>
<ol>
<li>Detection of virus inclusion bodies or free virus particles of large viruses, by examination of cells from inflammatory exudate by light or fluorescent microscopy.</li>
<li>Demonstration of virus particles in the specimen by electron microscopy.</li>
<li>Detection of viral antigens by immunological methods.</li>
<li>Demonstration of virus specific DNA or RNA in cellular exudate extracts by nucleic acid hybridization techniques.</li>
</ol>
<p>Table 3.2 summarises detection of viruses by direct methods.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="1-use-of-light-microscopy-for-viral-diagnosis">1. Use of Light Microscopy for Viral Diagnosis<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-use-of-light-microscopy-for-viral-diagnosis" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Viruses with the exception of the poxvirus group, are too small to be seen with even the highest magnification of the conventional light microscope. Poxviruses can be seen as eosinophilic featureless dust-like particles, lying extra-cellularly in the scrapings from the base of the vesicular lesions, in appropriately stained specimens. The viruses can be directly demonstrated as inclusion bodies in infected tissues and smears by light microscopy. Inclusion bodies are structures with distinct size, shape, location and staining properties. These are the sites of virus replication. As a general rule, viruses that assemble in the cytoplasm form intracytoplasmic inclusions, whereas those that assemble in the nucleus yield intranuclear inclusions. Inclusion bodies can be seen by staining methods such as Giemsa, Machiavello and Castaneda, haematoxylin and eosin or Papanicolaou methods. Fluorochromes such as acridine orange give very good results with viral nucleic acids when observed under fluorescent microscope.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="giemsa-staining-for-inclusion-bodies">Giemsa staining for inclusion bodies<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#giemsa-staining-for-inclusion-bodies" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p><strong>Intranuclear inclusion</strong> These can be observed in cells that have been infected by herpes simplex</p>
<p>Scanned by CamScanner</p>
<p>Medical Virology</p>
<p>Table 3.2 Direct methods for virus diagnosis</p>
<table><thead><tr><th>Suspected virus group</th><th>Microscopy</th><th>Immunological methods</th><th>Others</th></tr></thead><tbody><tr><td>Herpes simplex virus</td><td>Inclusion bodies, EM</td><td>IF, ELISA, RIA</td><td>NAH</td></tr><tr><td>Poxvirus</td><td>Inclusion bodies, EM</td><td>Gel diffusion, CF</td><td>-</td></tr><tr><td>Molluscum contagiosum virus</td><td>Inclusion bodies, EM</td><td>-</td><td>-</td></tr><tr><td>Influenza virus</td><td>-</td><td>IF, ELISA</td><td>-</td></tr><tr><td>Parainfluenza virus</td><td>-</td><td>IF</td><td>-</td></tr><tr><td>Respiratory syncytial virus (RSV)</td><td>-</td><td>IF, ELISA, RIA</td><td>-</td></tr><tr><td>Adenovirus</td><td>-</td><td>IF, ELISA, RIA</td><td>-</td></tr><tr><td>Cytomegalovirus (CMV)</td><td>Inclusion bodies</td><td>IF, ELISA, RIA</td><td>NAH</td></tr><tr><td>Measles virus</td><td>Inclusion bodies</td><td>IF, ELISA</td><td>-</td></tr><tr><td>Rotavirus</td><td>EM</td><td>ELISA</td><td>NAH</td></tr><tr><td>Adenovirus</td><td>EM</td><td>ELISA</td><td>-</td></tr><tr><td>Hepatitis A virus</td><td>EM</td><td>-</td><td>-</td></tr><tr><td>Hepatitis B virus</td><td>EM</td><td>-</td><td>Serological diagnosis</td></tr><tr><td>Poliovirus</td><td>-</td><td>-</td><td>Culture and serological diagnosis</td></tr><tr><td>Mumps virus</td><td>-</td><td>-</td><td>-</td></tr></tbody></table>
<p>Key: EM – Electron microscopy; IF – immunofluorescence; ELISA – Enzyme linked immunosorbent assay; RIA: radioimmunoassay; CF – complement fixation; NAH – nucleic acid hybridization</p>
<p>virus, varicella-zoster virus, cytomegalovirus, adenovirus and papovaviruses. The inclusion of herpes simplex and varicella-zoster appear similar and show a homogeneous, eosinophilic or slightly basophilic material in the nucleus. Nuclear chromatin, which is basophilic, is pushed against the edge of the nuclear membrane. The infected cells may be mononuclear or multinuclear. Cytomegalovirus produces basophilic nuclear inclusions in an enlarged cell. A clear halo is often observed around the inclusion. Adenoviruses produce a variety of inclusions. In early stages, the</p>
<p>inclusions are eosinophilic which become basophilic as they mature, and fill the nucleus. Eventually they become intensely basophilic and may completely distort the cell. These characteristic cells are called smudge cells. Intranuclear inclusions of papova virus in human warts begin as a granular eosinophilic matter and later condense into rounded basophilic masses.</p>
<p>Intracytoplasmic inclusions These may be seen in cells infected with respiratory syncytial virus (RSV), rabies virus and poxvirus group. RSV produces brightly eosinophilic intracytoplasmic inclus</p>
<p>Scanned by CamScanner</p>
<p>Diagnosis of Viral Disease 885</p>
<p>sions. Negri bodies, the intracytoplasmic inclusions of rabies virus, occur as eosinophilic masses in the cytoplasm of nerve cells. The edges of the inclusion are sharply demarcated. Vaccinia infected cells show rather small multiple inclusions called Guarnieri bodies. Inclusion bodies in molluscum contagiosum are very large eosinophilic bodies (20–30μm) which can be easily seen even under the low power of the microscope.</p>
<p>Measles virus produces both intracytoplasmic and intranuclear inclusions in the giant cells formed in the epithelial tissue. These are very large, multinucleated cells and show eosinophilic intranuclear inclusions similar to those produced by Herpes simplex virus. In addition, measles infected cells also contain brightly eosinophilic intracytoplasmic inclusions.</p>
<p><strong>Note</strong> For Giemsa staining technique, refer to Haematology section.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="fluorochrome-staining-for-inclusion-bodies">Fluorochrome staining for inclusion bodies<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#fluorochrome-staining-for-inclusion-bodies" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Fix the smear in 25% acetic acid (v/v) in methanol.</li>
<li>Prepare a 1 in 2000 to 1 in 4000 solution of acridine orange in acetate buffer, pH 3.0.</li>
<li>Flood the smear with the stain for 10 minutes.</li>
<li>Wash and mount in acetate buffer, pH 3. Examine in ultraviolet light.</li>
<li>Intranuclear or intracytoplasmic inclusion bodies exhibit fluorescence with various shades of green.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="2-electron-microscopy-em">2. Electron Microscopy (EM)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-electron-microscopy-em" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>A much higher magnification than that obtained by light microscopy is available by electron microscopy. All viruses can be seen by EM. However, an electron microscope is an expensive instrument which is not available in most laboratories. When available, it can be used to identify viruses in pathological specimens, biopsies and laboratory tissue cultures. Viruses can be detected in two ways, by direct method or by immune electron microscopy (IEM).</p>
<p>The material to be examined is suspended and centrifuged at low speed (300g for 10 minutes) to get rid of the debris. The supernatant can contain sufficient virus for EM preparations. This supernatant is centrifuged at high speed (e.g. 20,000g for 10 minutes) to concentrate the virus in the pellet. The concentrated virus is then transferred to a grid for EM. Grids for EM are made of copper and must be coated with a carbon film before use. The grid should be placed on a filter paper before transferring the material on to it. Alternatively, the clarified clinical material may be spun on to a grid placed at the bottom of the centrifuge tube. The grid is then air-dried.</p>
<p>Staining of virus particles is done by a negative staining method using salts of heavy metals such as uranyl acetate or phosphotungstic acid. This electron-dense material causes shadowing of the viruses present on the specimen grid which makes unstained virus particles stand out.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="direct-method">Direct method<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#direct-method" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Place drops of the staining solution on a sheet of parafilm.</li>
<li>The grid is floated upside down on the solution.</li>
<li>After the appropriate staining time, the grid is washed thrice by floating it on distilled water and subsequently air-dried on a filter paper. Watmaker's tweezers are used to manipulate the grids.</li>
<li>The grid is then placed in the electron microscope and scanned for virus particles.</li>
</ol>
<p>The EM can be used for the detection of virus particles from materials such as vesicular exudates from herpesvirus or poxvirus lesions, serum for hepatitis B virus or faecal extracts for rotavirus, Norwalk virus and poliovirus.</p>
<p>The diagnosis made by EM is morphological, based on the appearance of the virus particles. Since viruses from a group have the same morphology, it is not possible to identify them separately, and they cannot be typed by EM. For example, all</p>
<p>Scanned by CamScanner</p>
<p>886 Medical Virology</p>
<p>adenoviruses look alike irrespective of their serotype or pathogenicity. The procedure for quantitation of virus particles by EM is very cumbersome and not very accurate. However, it has a great advantage over light microscopy in that both intra or extracellular particles may be visualised by EM whereas intact cells are required for the detection of inclusion bodies by light microscopy. It is also useful for the detection of non-cultivable viruses. Figure 3.1(a,b,c) shows electron micrographs of some viruses.</p>
<p><img src="assets/images/image-20251219-852125d2.jpeg" alt="img-9.jpeg">
<strong>Fig. 3.1a</strong> Electron micrograph of Rabies virus</p>
<p><img src="assets/images/image-20251219-f22df651.jpeg" alt="img-10.jpeg">
<strong>Fig. 3.1b</strong> Electron micrograph of adenovirus</p>
<p><img src="assets/images/image-20251219-89a701ad.jpeg" alt="img-11.jpeg">
<strong>Fig. 3.1c</strong> Electron micrograph of hepatitis B (three forms) virus</p>
<p><strong>Immune Electron Microscopy (IEM)</strong> Immunological specificity may be added to EM identification in a number of situations. Pre-mixing the virus in a suspension with a homologous antibody usually causes the clumping of virus particles which are then more easily detected. This method is more sensitive than the direct method for EM.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="method">Method<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#method" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>
<p>Add the antiserum to a small volume of the specimen and incubate for 1–2 hours at 37°C. Spin on the grid at 20,000g for 10 minutes. Alternatively, the grid may be coated with the antiserum and then allowed to float on the surface of the specimen for 30–60 minutes at room temperature.</p>
</li>
<li>
<p>The grid is then air-dried and examined by EM. Virus particles aggregated by the antiserum are more easily seen than by direct microscopy.</p>
</li>
</ol>
<p>IEM is less useful with virus groups which have a large number of serotypes, such as enteroviruses. It is possible to detect only one serotype at a time.</p>
<p>Scanned by CamScanner</p>
<p>Diagnosis of Viral Disease 887</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="3-detection-of-viral-antigens-by-immunological-methods">3. Detection of Viral Antigens by Immunological Methods<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#3-detection-of-viral-antigens-by-immunological-methods" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Immunological techniques have been effectively used for the detection of certain viral antigens in tissues, exudates or culture cells. It is useful for identification of hepatitis A virus and rotavirus by direct examination of faecal specimens, because these viruses are not readily grown in cell-cultures.</p>
<p>Four types of immunoassays are commonly used for the viral antigen detection.</p>
<p>(i) Immunofluorescence test (IFT)
(ii) Enzyme-linked immunosorbent assay (ELISA or EIA)
(iii) Radioimmunoassay (RIA)
(iv) Immunoperoxidase staining</p>
<p>(i) Immunofluorescence tests (IFT) The IFT can be performed by two methods, direct and indirect.</p>
<p><strong>Direct Test:</strong> Specific antiserum is conjugated with fluorescein isothiocyanate and allowed to react with the specimen. The presence of antigen is detected by fluorescence when observed under a fluorescence microscope.</p>
<p><strong>Indirect Test:</strong> Unconjugated known specific antiserum is allowed to react with the specimen. The antigen is detected by adding anti-immunoglobulin conjugated with fluorescein isothiocyanate, which binds to the antibody.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="technique">Technique<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#technique" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="step-i">Step I<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#step-i" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p><strong>(a) Determination of optimum conjugate strength for direct IFT</strong></p>
<ul>
<li>
<p>Fix a known antigen, e.g. poliovirus infected cells, to 6 wells on a clean slide using cold acetone.</p>
</li>
<li>
<p>Make doubling dilutions of the conjugate (Specific antibody-fluorescein) from 1:10 to 1:320.</p>
</li>
<li>
<p>Add 10 μl of the first dilution to the first well, second dilution to the second well, and so on. Incubate at 37°C for 30 minutes in a moist chamber.</p>
</li>
<li>
<p>Wash in PBS for five minutes twice, and once in distilled water also for five minutes. Allow it to air-dry.</p>
</li>
<li>
<p>Examine under a UV microscope.</p>
</li>
<li>
<p>The optimum working strength of the conjugate is the highest dilution showing strong fluorescence.</p>
</li>
</ul>
<p><strong>(b) Determination of optimum conjugate strength for indirect IFT</strong></p>
<ul>
<li>Fix the known antigen to two rows of six wells on a slide using cold acetone.</li>
<li>To a row of six wells add 10 μl of positive control serum.</li>
<li>To another row of six wells add 10 μl of negative control serum.</li>
<li>Incubate at 37°C for 30 minutes in a moist chamber.</li>
<li>Wash in PBS for five minutes twice and once in distilled water also for five minutes. Allow to air-dry.</li>
<li>Make doubling dilutions of antiglobulin-fluorescein conjugate from 1:10 to 1:320 (1:10, 1:20, 1:40 ... 1:320)</li>
<li>Add 10 μl of each dilution serially to corresponding wells in both the rows.</li>
<li>Incubate at 37°C for 30 minutes in a moist chamber.</li>
<li>Repeat washing as above, and air-dry. Examine by fluorescence microscopy.</li>
<li>The optimum working strength of the antiglobulin-fluorescein conjugate is the highest dilution that shows a strong fluorescence.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="step-ii">Step II<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#step-ii" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p><strong>(a) Detection of viral antigen</strong></p>
<p><strong>Direct Test</strong></p>
<ul>
<li>Add 10 μl of the specimen to a clean glass slide, allow it to dry in air and fix in cold acetone for 10 minutes.</li>
<li>Add 10 μl of appropriate optimal dilution of specific antiserum conjugated with a fluorescent dye obtained in step I (a) above.</li>
<li>Incubate in a moist chamber at 37°C for 30 minutes.</li>
</ul>
<p>Scanned by CamScanner</p>
<p>Medical Virology</p>
<ul>
<li>Wash for five minutes twice in PBS and once in distilled water and air dry.</li>
<li>Include a positive and a negative control as for the test in two separate slides, with each batch of tests.</li>
<li>Examine by fluorescence microscopy. Specific immunofluorescence in the test well is a positive result.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="indirect-test">Indirect Test<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#indirect-test" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ul>
<li>Fix 10 µl of the specimen to a clean glass slide by cold acetone.</li>
<li>Add 10 µl of non-conjugated specific antibody and incubate at 37°C for 30 minutes in a moist chamber.</li>
<li>Wash in PBS twice for five minutes each and once in distilled water also for five minutes.</li>
<li>Add 10 µl of the optimum working strength of the antiglobulin-fluorescein conjugate obtained in (b) above.</li>
<li>Incubate at 37°C for 30 minutes in a moist chamber. Wash as instructed above, and dry in air.</li>
<li>Include a positive and a negative control for the antigen with each batch of tests.</li>
<li>Examine by a fluorescence microscopy.</li>
<li>A positive result is indicated by specific fluorescence in the test well.</li>
</ul>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ii-enzyme-linked-immunosorbent-assay-elisa">(ii) Enzyme-linked immunosorbent assay (ELISA)<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-enzyme-linked-immunosorbent-assay-elisa" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Two ELISA techniques can be used for antigen detection.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="a-sandwich-method">(a) Sandwich Method<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#a-sandwich-method" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Specific antibody is coated on a solid phase such as a microtitre plate. The antigen in the specimen is captured by the antibody. After washing, the captured antigen is spotted by the same antibody linked to an enzyme. After washing off the excess, presence of enzyme-labeled antibody can be detected by adding the substrate to produce a coloured reaction.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="b-competition-method">(b) Competition method<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b-competition-method" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>To a microtitre plate coated with specific antibody against the suspected antigen, a mixture of the known antigen labeled with enzyme (E) and an extract from a clinical material is added.</p>
<p>On addition of a specific substrate, the labelled antigen produces a colour reaction. If the antigen is present in the clinical specimen it can block some antibody combining sites, thus competing with the labeled antigen. The amount of antigen in the specimen is inversely proportional to the colour intensity.</p>
<p>If there is no antigen in the clinical material (unlabeled), all the antibody sites are occupied by the labeled antigen giving a strong colour reaction. This is a negative result. In Fig. 3.2, the clinical specimen contains antigen which attaches to the antibody, leaving little or no space for the labelled antigen. In this case, colour reaction is weak or absent. This is a positive test result.</p>
<p><img src="assets/images/image-20251219-8a4c5d80.jpeg" alt="img-12.jpeg">
Fig. 3.2 Competition method for the detection of antigen by ELISA</p>
<p>Microtitre plates of special quality and with flat bottomed wells are most commonly used as a solid phase in ELISA. The colour produced by the reaction of the enzyme label with its substrate is the basis for interpretation of the reaction, which can be read by a photometer. Determination of the exact value of the reaction by the photometer is possible only when sufficient controls are included. There must be a blank control, an antigen control, and a positive and a negative serum control. The nature of the colour produced depends on the enzyme and the substrate used.</p>
<p>Scanned by CamScanner</p>
<p>Diagnosis of Viral Disease 889</p>
<p>Washing is an essential step in an ELISA test. Multiwash and microplate washers can be very helpful to speed up operations and to prevent variations caused by manual operations. Accurate interpretation of the reaction colour of an ELISA test cannot be made by visual estimation. Special apparatus containing filters, photometers, microprocessors and so on are necessary for reproducible results. Some ELISA systems use antigen or antibody coated plastic bead as the solid phase. The advantage of the beads over microtitre plates is that a number of antigens can be used at the same time. After the reaction, the beads are washed in the buffer using a special washer and then, transferred into tubes. The enzyme-substrate reaction is performed in the tubes. Which are read individually in the computerized spectrophotometer.</p>
<p>(iii) Radioimmunoassay (RIA) for virus detection The RIA is based on the same principles as the ELISA, except that a radio-labelled antibody or antigen is used instead of an enzyme-linked antibody. The radioactive label most commonly used is <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mrow></mrow><mn>125</mn></msup><mi mathvariant="normal">I</mi></mrow><annotation encoding="application/x-tex">^{125}\mathrm{I}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8141em;"></span><span class="mord"><span></span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.8141em;"><span style="top: -3.063em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">125</span></span></span></span></span></span></span></span></span><span class="mord mathrm">I</span></span></span></span></span>.</p>
<p>The underlying principle of RIA is to select the most appropriate proportion of the radio-labelled antigen and its specific antibody so that they remain in a state of equilibrium. The equilibrium of this standard is then disturbed by adding the unlabelled antigen. A standard curve is obtained by measuring the radioactivity of varying known quantities of unlabelled antigen which competes with the labelled antigen for antibody sites. The concentration of viral antigen in the test sample can be determined by computing the resultant radioactivity from the standard curve.</p>
<p>The RIA test, though very sensitive, is used less commonly because of the restrictions imposed on work with radioactive substances. In most cases an ELISA can be used instead of RIA for the same information at lower cost and at less risk for the workers.</p>
<p>(iv) Immunoperoxidase staining The principle of immunoperoxidase staining is identical with that of direct immunofluorescence test except that the antiserum is labelled with an enzyme instead of fluorescein.</p>
<p>The clinical specimen is smeared on the slide, dried and fixed in acetone for 10 minutes. The enzyme-labelled specific antibody is allowed to react with the viral antigen in the smear. After washing, the enzyme substrate is added. A colour change is produced due to the action of the enzyme on the substrate. This change can be read macro- and microscopically.</p>
<p><strong>Note</strong> The endogenous peroxidase which may be present in the infected cells should be 'blocked' before immunoperoxidase staining by treating the smears with hydrogen peroxide.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="4-nucleic-acid-hybridization">4. Nucleic Acid Hybridization<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#4-nucleic-acid-hybridization" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Cells infected by viruses contain large amounts of viral nucleic acid, either DNA or RNA. The nucleotide sequences of a particular virus or a group of related viruses are unique. Therefore their detection offers a highly specific test for the presence of viruses.</p>
<p>The nucleic acid hybridization technique involves the use of nucleic acid probes. DNA consists of a double helix of two nucleotide chains with complementary bases that pair with one another, guanine with cytosine and adenine with thymine. By application of heat or in the presence of an alkali, this base pairing is broken and the two strands of DNA are separated. On removal of the denaturing conditions, the two strands with a complementary base sequence reunite or reanneal in a highly specific manner.</p>
<p>The basis of the nucleic acid hybridization or probe detection technique is the formation of duplexes between a nucleotide chain of the known viral origin, (the probe), and the chains of the same or similar base pairing (homology) in the clinical material. Thus, if a known DNA is denatured in solution and another species of DNA or RNA is mixed with it, mixed hybrids or duplexes may form between the nucleotide chains of the first and the</p>
<p>Scanned by CamScanner</p>
<p>Medical Virology</p>
<p>second DNA or RNA, under appropriate conditions. At the same time, however, some complementary chains of the original DNA will also reassociate and reanneal and compete with the new duplex or mixed strands.</p>
<p>Hybridization technique Denature a double stranded DNA by boiling for five minutes, or by treating with 0.5 mol/L sodium hydroxide, and quickly neutralize it with 0.5 mol/L hydrochloric acid in 1.5 mol/L sodium chloride. The DNA may be from the clinical material, and a known DNA may be treated separately as a control. Before reunion or reannealing of the separated strands can occur, the sample is filtered or spotted on to a nitrocellulose membrane. Single stranded DNA binds to nitrocellulose membrane. The nitrocellulose membrane is baked at an appropriate temperature, for example, at 80°C for two hours, to fix the strands in position (Fig. 3.3). Such target DNA can then be used for hybridization with one or more known probes.</p>
<p><img src="assets/images/image-20251219-8afd94db.jpeg" alt="img-13.jpeg">
Fig. 3.3 Sandwich hybridization on filters</p>
<p>For hybridization, a known complementary DNA probe is labelled either with a radio-isotope or with an enzyme. This probe is held in solution at an appropriate temperature, salt concentration and formamide concentration. Formamide is used as a denaturing agent. The target DNA fixed on the nitrocellulose membrane is then immersed in the solution containing the probe of target DNA. The hybrids of the target and the probe DNA strands form readily if they are complementary to each other. Unstable, mismatched hybrids can be washed off with buffers at varying temperatures and ionic strengths depending on the desired degree of homology between the target and probe DNA.</p>
<p>The extent of hybridization depends on the degree of relatedness between the two DNAs. The amount of mismatching between unrelated DNAs can be controlled by adjusting the temperature, salt concentration and formamide concentration. By increasing the temperature and formamide concentration, and reducing the salt concentration, the mismatching is reduced by a considerable degree. Also, the hybrids are more stable when washing is done at a high temperature or in low salt buffers.</p>
<p>More and more modifications of this basic technique are being used today to achieve greater sensitivity. The DNA probe can be prepared in various ways such as by propagation in a bacteriophage or in Escherichia coli containing antibiotic resistant plasmids.</p>
<p>The hybrids can be detected by measuring the radioactivity or by the use of a substrate for the enzyme label which will give a visible reaction. The polymerase chain reaction (PCR) is one of the newest techniques used for the detection of hybrids.</p>
<p>Nucleic acid hybridization technique has been successfully used for the diagnosis of infections caused by adenovirus, cytomegalovirus, herpes simplex virus, etc. Commercial kits are also available for hybridization assays.</p>
<p>Polymerase chain reaction (PCR) PCR is the best studied amplification technique since its inception in 1985. The method is an in vitro assay in which specific nucleic acid sequences are amplified. Double stranded target DNA is denatured by heat in the presence of two oligonucleotide primers. These primers flank the sequences to be amplified and they are complementary to opposite strands. DNA synthesis is repeated in cycles to perform in vitro replication of target nucleic acid sequences.</p>
<p>Each cycle of PCR comprises three stages: Stage 1: Target DNA is denatured by heating at 94°C. This causes the target DNA strands to separate and made acceptable for hybridization by specific oligonucleotide primers.</p>
<p>Scanned by CamScanner</p>
<p>Diagnosis of Viral Disease 891</p>
<p>Stage 2: At reduced temperature (40–60°C), the primers anneal to their complimentary target strands in a sequence in a specific manner.</p>
<p>Stage 3: The primers are extended on the DNA template by a DNA polymerase at a temperature of 73°C, and two short lengths of double stranded DNA are generated.</p>
<p>Thus, after each cycle of PCR, there are two double strands identical to the original one. Each extension product (new double strands) and the original one can serve as templates in second round of primer annealing and extension. As the number increases exponentially, thirty thermal cycles which take less than two hours, are sufficient to generate up to one billion copies of the original target DNA. The last step of PCR assay is the detection of amplified DNA. This is done by gel electrophoresis or hybridization to a specific probe.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="ii-isolation-and-identification-of-viral-agents">II. ISOLATION AND IDENTIFICATION OF VIRAL AGENTS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#ii-isolation-and-identification-of-viral-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Isolation of infecting virus in cell culture is the most sensitive method of diagnosing viral diseases. Some viruses are unable to proliferate in cell cultures. Such viruses may be cultivated in other alternative systems such as animals or embryonated eggs. Cultivation of viruses in various systems is described in Chapter 2.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="processing-specimens-for-inoculation">Processing Specimens for Inoculation<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#processing-specimens-for-inoculation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Collection and transport of specimens is described in Chapter 2. Clinical specimens need to be processed before they are inoculated into cell cultures. Turbid specimens are clarified by centrifugation. Antibiotic solutions may be added to prevent bacterial contamination. The procedure varies according to specimen. General guidelines are provided below.</p>
<p>Swabs (throat, nasal, genital or from lesions): Swabs are received in the transport medium. If not, place the swab in 3–4 ml of viral transport medium (VTM). Mix on a vortex mixer for 30 seconds.</p>
<p>Press the swab against the wall of the container to express the fluid. Discard the swab. Centrifuge the fluid at 1500 g for 10 min. Use the clear supernatant fluid to inoculate cell cultures.</p>
<p>CSF and other body fluids: Clear specimen does not need any processing. Centrifuge turbid specimens at 1500 g for 10 minutes. Use the supernatant to inoculate the cell culture.</p>
<p>Urine: Transfer 10 ml of the specimen to a sterile centrifuge tube. Add 0.05 ml of 50 μg/ml gentamicin and 0.05 ml of 250 μg/ml of amphotericin B. Mix well and incubate at room temperature for 30–45 minutes. Centrifuge at 1500 g for 10 min. Decant the supernatant into another sterile container. Use the supernatant to inoculate the cell cultures except the diploid fibroblast cultures. Vortex the deposit in the centrifuge tube and use it for inoculating the diploid fibroblast cultures.</p>
<p>Faeces: Mix a pea-sized portion of the specimen in about 3–4 ml of VTM and spin at 1500 g for 10 minutes. Filter the supernatant through 0.45 μm pore-size sterile filter. Syringe-top filters are convenient to use. Inoculate the cell cultures with the filtered fluid. Follow the same procedures of centrifugation and filtration for the rectal swabs in VTM.</p>
<p>Tissue: Grind the tissue in 3–4 ml of VTM in a sterile grinder. Centrifuge the ground tissue in VTM at 1500 g for 10 mins. If the supernatant is still turbid, filter it through 0.45 μm filter. Use the clear fluid for inoculation.</p>
<p>Anticoagulated blood: Use mononuclear cells in blood as the inoculum for cell cultures. These cells can be separated by centrifugating the blood over a mixture of Ficoll and Hypaque. After centrifugation, red blood cells and polymorphs settle at the bottom of the tube, leaving the mononuclear cells at the junction of the Ficoll-Hypaque mixture and the blood plasma. Harvest the mononuclear cells carefully for inoculation.</p>
<p>&gt; <strong>Note</strong>
&gt; If possible, mix a small portion of each processed specimen with 5% glycerol and freeze at –70°C. This can be used later for additional or follow-up tests.</p>
<p>Scanned by CamScanner</p>
<p>Medical Virology</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="selection-of-cell-lines-for-virus-isolation">Selection of Cell-lines for Virus Isolation<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#selection-of-cell-lines-for-virus-isolation" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Generally, several types of cell-lines are used for each specimen to allow the growth and proliferation of each virus that may be present. A cell-line that is known to support the growth of the suspected virus, and that, will give a characteristic, cytopathic effect, should preferably be selected. If a provisional clinical diagnosis is not available, two tubes each of a primary, diploid and continuous cell-line are recommended so that there is a chance to recover a wide range of viruses from the specimen. The most commonly used cell-lines include:</p>
<p>(i) Primary monkey kidney (PMK)
(ii) Human diploid fibroblasts (HDF)
(iii) HEp-2
(iv) African green monkey kidney (Vero)</p>
<p>Once a cell-line is found to be acceptable, keep multiple aliquots of each line frozen at <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>−</mo><msup><mn>70</mn><mo lspace="0em" rspace="0em">∘</mo></msup><mi mathvariant="normal">C</mi></mrow><annotation encoding="application/x-tex">-70^{\circ}\mathrm{C}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.7667em; vertical-align: -0.0833em;"></span><span class="mord">−</span><span class="mord">7</span><span class="mord"><span class="mord">0</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.6741em;"><span style="top: -3.063em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">∘</span></span></span></span></span></span></span></span></span><span class="mord mathrm">C</span></span></span></span></span> in liquid nitrogen as stock cultures. Keep the cells for routine use in continuous culture. Replenish these cultures periodically by the stock cultures in liquid nitrogen. Cell culture techniques are described in Chapter 2.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="inoculation-of-specimens">Inoculation of Specimens<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#inoculation-of-specimens" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Before inoculation, check that the monolayers of selected cell-lines are confluent. Discard monolayers showing overgrown and old cells. Use two tubes of each cell-line for one specimen along with an uninoculated control tube. There are two methods of inoculation of the specimen.</p>
<p><strong>Direct method:</strong> Add <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>0.2</mn><mrow><mi mathvariant="normal">m</mi><mi mathvariant="normal">l</mi></mrow></mrow><annotation encoding="application/x-tex">0.2\mathrm{ml}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord">0.2</span><span class="mord"><span class="mord mathrm">ml</span></span></span></span></span></span> of the processed specimen directly into the cell culture tube without removing the medium.</p>
<p><strong>Adsorption method:</strong> Discard the growth medium in the cell culture tube. Add <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>0.2</mn><mrow><mi mathvariant="normal">m</mi><mi mathvariant="normal">l</mi></mrow></mrow><annotation encoding="application/x-tex">0.2\mathrm{ml}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord">0.2</span><span class="mord"><span class="mord mathrm">ml</span></span></span></span></span></span> of the specimen directly on the cell monolayer. Incubate at <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mn>36</mn><mo lspace="0em" rspace="0em">∘</mo></msup><mi mathvariant="normal">C</mi></mrow><annotation encoding="application/x-tex">36^{\circ}\mathrm{C}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6833em;"></span><span class="mord">3</span><span class="mord"><span class="mord">6</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.6741em;"><span style="top: -3.063em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">∘</span></span></span></span></span></span></span></span></span><span class="mord mathrm">C</span></span></span></span></span> for 30-45 minutes to enhance adsorption of the virus to the cells in the monolayer. Rock the tube gently after 20 minutes for better adsorption. Add <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>2.0</mn><mrow><mi mathvariant="normal">m</mi><mi mathvariant="normal">l</mi></mrow></mrow><annotation encoding="application/x-tex">2.0\mathrm{ml}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6944em;"></span><span class="mord">2.0</span><span class="mord"><span class="mord mathrm">ml</span></span></span></span></span></span> of maintenance medium to cover the cell monolayer.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="examination-of-cell-cultures">Examination of Cell Cultures<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#examination-of-cell-cultures" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<ol>
<li>Incubate the inoculated cultures at <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><msup><mn>36</mn><mo lspace="0em" rspace="0em">∘</mo></msup><mi mathvariant="normal">C</mi></mrow><annotation encoding="application/x-tex">36^{\circ}\mathrm{C}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.6833em;"></span><span class="mord">3</span><span class="mord"><span class="mord">6</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.6741em;"><span style="top: -3.063em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">∘</span></span></span></span></span></span></span></span></span><span class="mord mathrm">C</span></span></span></span></span> for two weeks. If CMV is suspected, continue incubation up to four weeks.</li>
<li>Examine the cell cultures both macroscopically and microscopically at least three times a week.</li>
<li>Look for evidence of viral proliferation, toxicity or contamination.</li>
<li>In case of contamination, it is advisable to discard the cultures. Fresh monolayers can be inoculated with the portion of the processed specimen frozen at <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mo>−</mo><msup><mn>70</mn><mo lspace="0em" rspace="0em">∘</mo></msup><mi mathvariant="normal">C</mi></mrow><annotation encoding="application/x-tex">-70^{\circ}\mathrm{C}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.7667em; vertical-align: -0.0833em;"></span><span class="mord">−</span><span class="mord">7</span><span class="mord"><span class="mord">0</span><span class="msupsub"><span class="vlist-t"><span class="vlist-r"><span class="vlist" style="height: 0.6741em;"><span style="top: -3.063em; margin-right: 0.05em;"><span class="pstrut" style="height: 2.7em;"></span><span class="sizing reset-size6 size3 mtight"><span class="mord mtight"><span class="mord mtight">∘</span></span></span></span></span></span></span></span></span><span class="mord mathrm">C</span></span></span></span></span>. If the additional specimen is not available, filter the supernatant from the contaminated culture with <span class="math math-inline"><span class="katex"><span class="katex-mathml"><math xmlns="http://www.w3.org/1998/Math/MathML"><semantics><mrow><mn>0.45</mn><mi>μ</mi><mi mathvariant="normal">m</mi></mrow><annotation encoding="application/x-tex">0.45\mu\mathrm{m}</annotation></semantics></math></span><span class="katex-html" aria-hidden="true"><span class="base"><span class="strut" style="height: 0.8389em; vertical-align: -0.1944em;"></span><span class="mord">0.45</span><span class="mord mathnormal">μ</span><span class="mord mathrm">m</span></span></span></span></span> filter. Use the filtrate to inoculate fresh cell culture tubes. For microscopic examination, a conventional light microscope or an inverted microscope can be used. A tube holder can be used while examining under the microscopes. The monolayer can be examined under the 10X objective.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="detection-of-viral-growth-in-cell-cultures">Detection of Viral Growth in Cell Cultures<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#detection-of-viral-growth-in-cell-cultures" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Many viruses produce degenerative changes in the cell monolayer during their proliferation. These changes can be observed microscopically. However, some viruses do not produce any change that can be detected microscopically. Other methods of detection are necessary for such viruses.</p>
<p>The methods commonly used for the detection of viral proliferation in cell cultures include:</p>
<ol>
<li>Cytopathic effect (CPE)</li>
<li>Haemagglutination</li>
<li>Haemadsorption</li>
<li>Interference challenge</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="1-cytopathic-effect">1. Cytopathic effect<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-cytopathic-effect" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>When a virus grows in a cell monolayer, it may bring about destruction of cells, thereby changing the appearance of the monolayer. This change or destruction is called cytopathic effect (CPE). It is characteristic for an</p>
<p>Scanned by CamScanner</p>
<p>Diagnosis of Viral Disease 893</p>
<p>individual virus or a group of viruses. Many types of CPE can be seen in unstained cell monolayers, while some types are seen only in stained preparations. The CPE usually starts as a focus or multiple foci. It later spreads all over the monolayer. The rate and pattern of CPE depends upon:</p>
<p>(i) The type of cell monolayer.
(ii) The properties of the infecting virus.
(iii) The concentration of the virus in the specimen.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="changes-in-cell-monolayers-due-to-cpe">Changes in cell monolayers due to CPE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#changes-in-cell-monolayers-due-to-cpe" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>(a) General morphological changes: The CPE is most commonly initiated by the rounding up of cells which may then become swollen or shrunk. These cells have a tendency to break loose from the monolayer and float freely on the surface of the medium. Some infected cells form grape-like clusters while some may get enlarged.</p>
<p>(b) Syncytium formation: A syncytium is a multinucleated giant cell which results from the fusion of virus infected cells. Syncytia can vary in size and some such cells may contain up to 100 nuclei.</p>
<p>(c) Cellular granulation: Some viruses cause granulation of the cytoplasm. It should not be confused with the non-specific degeneration caused by aging of cells.</p>
<p>(d) Vacuolation: Large, frothy, bubble-like vacuoles are formed by some viruses in the cytoplasm of infected cells.</p>
<p>(e) Nuclear destruction: Destruction of the nuclear material by some viruses can be detected in stained preparations.</p>
<p>(f) Formation of inclusion bodies: Inclusion bodies, similar to those observed directly in the clinical specimens, can be observed in the stained preparations of the infected cells. The inclusions may be single or multiple, small or large, acidophilic or basophilic, and intranuclear or intracytoplasmic.</p>
<p>Figures 3.4a and b show a normal HEp-2 monolayer and CPE by adenovirus and RSV.</p>
<p><img src="assets/images/image-20251219-fd202417.jpeg" alt="img-14.jpeg">
Fig 3.4a Normal HE-2 monolayer</p>
<p><img src="assets/images/image-20251219-abc313ed.jpeg" alt="img-15.jpeg">
Fig 3.4 b (i) CPE due to infection with adenovirus</p>
<p><img src="assets/images/image-20251219-a5ac5d58.jpeg" alt="img-16.jpeg">
Fig. 3.4b (ii) CPE due to infection with respiratory syncytial virus</p>
<p>Scanned by CamScanner</p>
<p>Medical Virology</p>
<p>Recording CPE Observe the uninoculated control tube before examining the CPE to assess the changes in the cells due to natural aging or due to environmental conditions. Record the CPE in the test semiquantitatively as follows:</p>
<ul>
<li>If less than 25% of the cell monolayer is affected
++ If 25–50% is affected
+++ If 51%–75% is affected
++++ If more than 75% is affected.</li>
</ul>
<p>Table 3.3 shows methods of cultivation, CPE and confirmatory tests for identification of some viruses.</p>
<ol start="2">
<li>Haemagglutination Some viruses have surface projections or spikes for which erythrocytes possess complementary receptor sites. Such viruses, when mixed with appropriate erythrocytes, are capable of binding them. This binding produces visible agglutination and is known as viral haemagglutination. The viral surface projections are proteins and are called haemagglutinins. The receptor sites on erythrocytes are not immunoglobulins and therefore, viral haemagglutination is not an antigen-antibody reaction. Some viruses can agglutinate red cells of various animal species whereas others may agglutinate red cells of only one specific species. The optimum temperature and pH for agglutination varies with the type of virus. Table 3.4 shows characteristics of some haemagglutinating viruses.</li>
</ol>
<p>If a haemagglutinating virus, for example, Influenza virus, is suspected to be growing in the cell monolayer, it can be detected and quantitated with the help of haemagglutination (HA) test.</p>
<p>To determine haemagglutination (HA) titre of a virus</p>
<p>Principle</p>
<p>Viral suspension e.g. washed cell monolayer infected with the virus, is diluted in microtitre wells or test tubes in doubling dilutions. A constant volume of red cell suspension of appropriate species is added to each dilution. The tubes are incubated at appropriate temperature. Agglutination indicates presence of virus. Agglutinated cells are seen</p>
<p>as a shield-like pattern while those which are not agglutinated settle as a sharp red dot at the bottom to form a 'button' (Fig. 3.5). The highest dilution that produces haemagglutination is the haemagglutination (HA) titre of the suspension.</p>
<p><img src="assets/images/image-20251219-982c1296.jpeg" alt="img-17.jpeg">
Fig. 3.5 The pattern of haemagglutination</p>
<p>Technique</p>
<ol>
<li>Place 25 µl of diluent (PBS or saline) in 11 wells of the microtitre plate. The eleventh well acts as a cell control.</li>
<li>Place 25 µl of viral suspension in the first well to make 1:2 dilution and mix.</li>
<li>Transfer 25 µl from the first well to the second well (1:4 dilution); continue till the tenth well.</li>
<li>Discard 25 µl from the tenth well.</li>
<li>Add 25 µl of appropriate red cell suspension to all wells including the cell control.</li>
<li>Incubate at appropriate temperature (see Table 3.4) until the control cells have settled to a discrete button.</li>
<li>Read the HA titre of the virus as the highest dilution that gives haemagglutination.</li>
</ol>
<p>Figure 3.6 shows a microtitre plate of haemagglutination test for influenza virus on eight specimens—A to H. Each specimen is diluted from 1:2 (well 1) to 1:2048 (well 11). The last (twelfth) row is the red cell control which does not contain virus specimen. All the specimens show a positive test with varying HA titres. Specimen C shows the highest titre (1024).</p>
<p>Note</p>
<p>(1) The HA test is useful only for those viruses which are capable of haemagglutination.</p>
<p>Scanned by CamScanner</p>
<p>Table 3.3 Methods of cultivation and identification of viruses</p>
<table><thead><tr><th>Virus</th><th>Primary isolation in</th><th></th><th></th><th></th><th></th><th></th></tr></thead><tbody><tr><td></td><td>PMK</td><td>HEP2</td><td>HDF</td><td>Rate of growth (days)</td><td>CPE</td><td>Confirmatory tests</td></tr><tr><td>Influenza</td><td>+</td><td>-</td><td>-</td><td>2-10</td><td>None or degeneration with swollen, vacuolated cells</td><td>HAI, IF, CF</td></tr><tr><td>Parainfluenza</td><td>+</td><td>+</td><td>-</td><td>4-10</td><td>None or focal rounding and multinucleated giant cells</td><td>HAI, IF, CF</td></tr><tr><td>Respiratory syncytial virus (RSV)</td><td>+</td><td>+</td><td>+</td><td>3-10</td><td>Syncytia in PMK and HEP-1. Focal degeneration in HDF</td><td>IF, NT, ELISA</td></tr><tr><td>Mumps virus</td><td>+</td><td>±</td><td>±</td><td>5-10</td><td>Usually absent, large syncytia may be seen</td><td>HAI, NT</td></tr><tr><td>Measles virus</td><td>+</td><td>+</td><td>-</td><td>-</td><td>Rarely isolated, may show vacuolated syncytia</td><td>NT, IF</td></tr><tr><td>Pohovirus</td><td>+</td><td>+</td><td>+</td><td>2-8</td><td>Swollen, refractile cells, rapid progression to the entire monolayer, cells detached</td><td>IF, NT, ELISA</td></tr><tr><td>Coxsackie B virus</td><td>+</td><td>+</td><td>-</td><td>2-8</td><td></td><td></td></tr><tr><td>Echovirus</td><td>+</td><td>-</td><td>+</td><td>2-8</td><td></td><td></td></tr><tr><td>Adenovirus</td><td>+</td><td>+</td><td>±</td><td>2-10</td><td>Rounded cells in grape-like clusters</td><td>NT, IF, CF</td></tr><tr><td>Herpes simplex virus</td><td>±</td><td>+</td><td>+</td><td>1-3</td><td>Rounded, swollen cells, occasional syncytia, rapid destruction of the entire monolayer</td><td>IF, ELISA</td></tr><tr><td>Cytomegalovirus</td><td>-</td><td>-</td><td>+</td><td>5-21</td><td>Distinct foci of enlarged cells, slow progression</td><td>IF, H&amp;E</td></tr><tr><td>Varicella-zoster virus</td><td>±</td><td>-</td><td>+</td><td>4-10</td><td>Discrete, elongated foci of enlarged or shrunken cells</td><td>IF, CF</td></tr></tbody></table>
<p>PMK = Primary monkey kidney
H&amp;E = Haematoxylin and eosin staining
CF = Complement fixation
ELISA = Enzyme linked immunosorbant assay
HAI = Haemagglutination inhibition
NT = Neutralisation test
HDF = Human Diploid fibroblasts
IF = Immunofluorescence</p>
<p>Scanned by CamScanner</p>
<p>Medical Virology</p>
<p>Table 3.4 Characteristics of haemagglutination by viruses</p>
<table><thead><tr><th>Virus</th><th>Erythrocyte species</th><th>Other conditions</th></tr></thead><tbody><tr><td>Influenza virus</td><td>Fowl, human, guinea pig, others</td><td>Elution at 37°C</td></tr><tr><td>Parainfluenza, Mumps</td><td>Fowl, human, guinea pig, others</td><td>Elution at 37°C haemolysin present</td></tr><tr><td>Measles</td><td>Monkey</td><td>37°C</td></tr><tr><td>Togavirus—several groups of Arbovirus</td><td>Goose, pigeon, one day old chick</td><td>pH and temperature critical</td></tr><tr><td>Rubella</td><td>Goose, pigeon, one day old chick</td><td>4°C</td></tr><tr><td>Enterovirus—some Coxsackie and ECHO serotypes</td><td>Human</td><td>4°C and 37°C</td></tr><tr><td>Rhinovirus, some serotypes</td><td>Sheep</td><td>4°C</td></tr><tr><td>Rabies</td><td>Goose</td><td>4°C, pH 6.2</td></tr><tr><td>Reovirus</td><td>Human</td><td>37°C</td></tr><tr><td>Adenovirus</td><td>Monkey, rat</td><td>Divided into 4 groups depending on HA of monkey, rat, both or neither</td></tr><tr><td>Polyomavirus</td><td>Guinea pig</td><td>4°C</td></tr></tbody></table>
<p>(ii) It does not provide a definitive identification, but only indicates the presence of a haemagglutinating virus.</p>
<p><img src="assets/images/image-20251219-5c8cd296.jpeg" alt="img-18.jpeg">
Fig. 3.6 Haemagglutination test</p>
<ol start="3">
<li>Haemadsorption The surfaces of some virus infected cells are altered in such a way that erythrocytes adhere to them. This adherence of red cells to the virus infeted cells is called haemadsorption. The viruses which are capable of inducing haemadsorption (HAD) are influenza, parainfluenza, mumps and measles. Most of these viruses are also capable of haemagglutination. A modification of haemadsorption test can detect both haemadsorption and haemagglutination.</li>
</ol>
<p>Technique</p>
<ol>
<li>Remove the culture fluid from the cell culture tube containing infected cells.</li>
<li>Add 2ml of 0.08% guinea pig erythrocyte suspension to the culture tube.</li>
<li>Repeat the same procedure with an uninfected cell line of the same type.</li>
<li>Place the tubes in a slanted position so that the erythrocyte suspension covers the monolayer.</li>
</ol>
<p>Scanned by CamScanner</p>
<p>Diagnosis of Viral Disease 897</p>
<ol start="5">
<li>
<p>Incubate at 4°C for 30 minutes.</p>
</li>
<li>
<p>Examine microscopically for the adherence of erythrocytes to the infected cells. The haemadsorption appears as rosettes of erythrocytes covering the cell surface.</p>
</li>
<li>
<p>To observe haemagglutination, allow the tubes to stand vertically overnight at room temperature.</p>
</li>
<li>
<p>Observe the red cells at the bottom of the tube.</p>
</li>
<li>
<p>If the red cells show a shield pattern, the culture is positive for haemagglutination.</p>
</li>
<li>
<p>If the red cells settle to form a button, the haemagglutination test is negative.</p>
</li>
<li>
<p>The negative control tube should show the absence of both haemadsorption and haemagglutination.</p>
</li>
<li>
<p>Interference challenge Some viruses do not produce any CPE during their growth in a cell culture. The presence of such viruses can be detected by a second virus which is capable of producing a characteristic CPE in the cell culture. This CPE producing virus is called the challenge virus. In the presence of another virus, this challenge virus is unable to replicate and produce CPE. Because the first virus interferes with the growth of the challenge virus, this technique is called interference challenge test.</p>
</li>
</ol>
<p><strong>Technique</strong></p>
<ol>
<li>Inoculate the clinical specimen into the cell culture medium.</li>
<li>Incubate for up to two weeks at 36°C.</li>
<li>If no CPE is observed in the cell monolayer, introduce a standard dose of a known cytopathogenic challenge virus into the culture. Continue incubation.</li>
<li>Examine the culture for the CPE of the challenge virus.</li>
</ol>
<p>If the clinical specimen contained a virus, its presence in the cell monolayer will prevent the replication of the challenge virus. Therefore, there will be no CPE in the cell monolayer.</p>
<p>If the clinical specimen did not contain any virus, there will be no interference with the replication of the challenge virus. A characteristic CPE of the challenge virus will be observed in the cell culture.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="identification-of-viral-isolates">Identification of Viral Isolates<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#identification-of-viral-isolates" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>There are many methods available for the identification of a virus isolated from a clinical specimen. Most of these methods use a known specific antibody to identify an unknown isolate. The same methods can also be modified for the direct identification of a viral antigen in a clinical specimen; or can be reversed and used for the detection of unknown antibodies with the help of known viral antigens.</p>
<p>The tests most commonly used for the identification of viral isolates are:</p>
<ol>
<li>Neutralization tests</li>
<li>Immunofluorescence (IF) test</li>
<li>Enzyme-linked immunosorbent assay (ELISA or EIA)</li>
<li>Complement fixation test (CFT)</li>
<li>Nucleic acid hybridization test.</li>
</ol>
<p>The principles of IF, EIA, ELISA and CFT are described in the Clinical Immunology section. The methods used for the direct detection of viruses in the clinical specimen can also be used for the identification of isolates. These tests are available in kit forms. The manufacturer's directions should be followed to perform the tests.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="neutralization-tests">Neutralization tests<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#neutralization-tests" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>A virus binds with a corresponding specific antibody and becomes 'neutralized' i.e. it becomes non-infectious due to the blockage of critical sites by antibody molecules. When a neutralized virus is tested by a virus detection system, such as CPE in a cell monolayer or haemagglutination, the characteristic evidence of its presence does not appear. The absence of evidence establishes the identity of the infecting virus.</p>
<p>Two types of neutralization tests are commonly used for virus identification:</p>
<p>(i) Neutralization of CPE of cytopathogenic viruses
(ii) Haemagglutination inhibition test</p>
<p>Scanned by CamScanner</p>
<p>Medical Virology</p>
<p>Neutralization test for cytopathogenic viruses
The neutralization test is performed in three steps.</p>
<p>Step I: Preparation of the virus inoculum</p>
<ul>
<li>Determine the titre of the isolated virus in the culture tube as follows:</li>
<li>Remove the supernatant fluid from the cell culture tube (viral suspension).</li>
<li>Prepare two fold serial dilutions of the viral suspension in minimum essential medium (MEM) containing 2% foetal bovine serum.</li>
<li>Inoculate 0.2ml of each dilution onto a fresh cell monolayer in duplicate.</li>
<li>Inoculate 0.2ml of MEM onto a separate monolayer to serve as a control.</li>
<li>Incubate at 36°C for four days.</li>
<li>Examine the tubes for CPE. The dilution at which 50% cells are infected is the tissue culture infective dose (TCID₅₀) of the virus. For example, in case of 1:200 dilution, the 100 TCID₅₀ of the viral suspension is 1:2 dilution.</li>
<li>In the same way, determine the 100 TCID₅₀ of the known reference virus.</li>
</ul>
<p>Step II: Standardization of the antibody</p>
<ul>
<li>Prepare serial dilutions of a known antibody for the suspected virus, ranging from 1:10 to 1:640.</li>
<li>Mix 0.2ml of each dilution with 0.2ml of 100 TCID₅₀ virus suspension of a known reference strain.</li>
<li>Incubate for 1 hour at room temperature.</li>
<li>Inoculate 0.2ml of each mixture onto fresh cell monolayers in culture tubes.</li>
<li>The dilution of the antibody which protects at least half of the cells from viral CPE is equivalent to 1 unit of antibody.</li>
<li>Dilute the antibody in such a way that 0.2ml of the dilution contains 20 units.</li>
</ul>
<p>Step III: Identification of the virus isolate</p>
<ul>
<li>Mix 0.2 ml of the virus isolate containing 100 TCID₅₀ with 0.2ml of the dilution of the antibody containing 20 units.</li>
<li>Mix 0.2 ml of 100 TCID₅₀ of the reference virus in the same way.</li>
<li>Incubate at room temperature for 1 hour for the neutralization to occur.</li>
<li>Inoculate 0.2 ml of each mixture onto cell monolayers in tubes.</li>
<li>Incubate at 36°C. Examine every alternate day.</li>
</ul>
<p>Results
Protection of the cell monolayer from the viral CPE by the specific antibody identifies the isolate. In the absence of neutralization, the viral CPE will appear.</p>
<p>Haemagglutination inhibition (HAI) test
Haemagglutination inhibition (HAI) test can be used for definitive identification of viruses which are capable of haemagglutinating. When such a virus is reacted with its specific antibody its capacity to haemagglutinate is neutralized or inhibited (Fig. 3.7). This test may also be used for the detection and measurement of antibodies against haemagglutinating viruses.</p>
<p>The HAI test is performed in two steps.</p>
<p>Step I: Determination and standardisation of HA titre</p>
<ul>
<li>Determine the HA titre of both the isolate and the known reference strain of the suspected virus using RBCs of appropriate species (Table 3.4). Haemagglutinating unit (HAU) is contained in the highest dilution of virus showing haemagglutination.</li>
<li>Prepare a viral suspension equivalent to 4HAU in 25 μl.</li>
</ul>
<p>For example, if 50 μl of 1:320 dilution contains 1HAU, 50 μl of 1:40 dilution will contain 8HAU and 25 μl of 1:40 dilution will contain 4HAU.</p>
<p>Step II: Haemagglutination inhibition</p>
<ul>
<li>Dilute a known specific antibody for both the suspected and the reference viruses.</li>
<li>Prepare two fold dilutions of the antibody from 1:10 to 1:2560 in 25 μl amounts in two rows in a microtitre plate.</li>
<li>In the first row add 25 μl of the virus isolate suspension (4HAU) to each well.</li>
</ul>
<p>Scanned by CamScanner</p>
<p>Diagnosis of Viral Disease 899</p>
<p><img src="assets/images/image-20251219-1afcb6cd.jpeg" alt="img-19.jpeg"></p>
<p><img src="assets/images/image-20251219-054d27ae.jpeg" alt="img-20.jpeg"></p>
<p>Fig. 3.7 Principle of viral haemagglutination inhibition</p>
<ul>
<li>In the second row, add 25μl of the reference virus suspension (4HAU) to each well.</li>
<li>Include one well each of serum control (serum and PBS), antigen control (viral suspension and PBS) and RBC control (PBS only) in 25μl volumes.</li>
<li>Mix and incubate at room temperature for 30 minutes.</li>
<li>Add 50 μl of the 5% RBC suspension to each well. Shake to mix and incubate till the cell control shows a button at the bottom of the well.</li>
</ul>
<p>Results</p>
<ul>
<li>
<p>Check the controls. The positive reference control should show no agglutination, antigen control should show agglutination and the RBC control should form a red cell button (no agglutination).</p>
</li>
<li>
<p>Inhibition of agglutination by the test virus indicates a positive test.</p>
</li>
<li>
<p>Identity of the test virus is indicated by the specificity of the antibody that inhibits agglutination.</p>
</li>
</ul>
<p>Nucleic acid hybridization test Nucleic acid hybridization technique, as described in the direct detection of viruses in clinical specimens, can also be used to identify virus isolates.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="iii-serodiagnosis-of-viral-infections">III SERODIAGNOSIS OF VIRAL INFECTIONS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#iii-serodiagnosis-of-viral-infections" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Serodiagnosis of viral infections involves detection of antibodies to viral antigens in patient’s serum in sufficiently high titres.</p>
<p>Scanned by CamScanner</p>
<p>900 Medical Virology</p>
<p>The procedures commonly used for serological diagnosis of viral infections include the following.</p>
<ol>
<li>Indirect immunofluorescence (IF) test</li>
<li>Enzyme linked immunosorbent assay (ELISA) or enzyme immunoassay (EIA)</li>
<li>Neutralization (NT) test</li>
<li>Complement fixation (CF) test.</li>
</ol>
<p>The principles involved in the performance of the above tests are already described. They are employed for the identification of viral isolates by using a known antiserum against the suspected virus.</p>
<p>The same methods can be adapted for the detection of an antibody by using a known reference virus. The antibody can be titrated by using a range of dilutions.</p>
<p>Out of the above mentioned tests, the IF and ELISA are the most commonly used because they are sensitive, easy to perform and less time consuming than other tests such as CF and NT. Tests kits for the above are available commercially.</p>
<p>Table 3.5 shows the serological tests used for some commonly occurring viral infections.</p>
<p>Table 3.5 Serological tests for diagnosis of viral infections</p>
<table><thead><tr><th>Virus</th><th>Tests performed</th></tr></thead><tbody><tr><td><strong>Respiratory Infections</strong></td><td></td></tr><tr><td>Influenza A and B</td><td>CF; HAI</td></tr><tr><td>Parainfluenza virus</td><td>HAI; CF; ELISA</td></tr><tr><td>Respiratory syncytial virus</td><td>CF; ELISA</td></tr><tr><td>Adenovirus</td><td>CF; ELISA</td></tr><tr><td><strong>Central Nervous System Infections</strong></td><td></td></tr><tr><td>Enteroviruses</td><td>CF; NT; ELISA</td></tr><tr><td>Mumps virus</td><td>HAI; IF; ELISA</td></tr><tr><td>Herpes simplex virus</td><td>CF; ELISA; IF</td></tr><tr><td>Rabies virus</td><td>IF</td></tr><tr><td><strong>Hepatitis</strong></td><td></td></tr><tr><td>Hepatitis A</td><td>RIA; ELISA</td></tr><tr><td>Hepatitis B</td><td>RIA; ELISA</td></tr><tr><td><strong>Cutaneous Infections</strong></td><td></td></tr><tr><td>Measles virus</td><td>HAI; IF; ELISA; CF</td></tr><tr><td>Varicellazoster virus</td><td>CF; IF</td></tr><tr><td><strong>Other Infections</strong></td><td></td></tr><tr><td>Cytomegalovirus</td><td>ELISA; CF; HAI; IF</td></tr><tr><td>Rubella</td><td>HAI; ELISA;</td></tr><tr><td>IF; Heterophile test.</td><td></td></tr><tr><td><strong>Epstein-Barr virus</strong></td><td>ELISA</td></tr><tr><td>HIV (AIDS)</td><td>Immunodot assays, ELISA, IF</td></tr><tr><td></td><td>Western blot assay</td></tr><tr><td>CF—complement fixation; HAI—hemagglutination inhibition; NT—viral neutralization;</td><td></td></tr><tr><td>IF—immunofluorescence; RIA—radioimmunoassay; ELISA—Enzyme-linked immunosorbent assay</td><td></td></tr></tbody></table>
<p>Scanned by CamScanner</p>
<p>Diagnosis of Viral Disease 901</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="interpretation-of-viral-serological-tests">Interpretation of Viral Serological Tests<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#interpretation-of-viral-serological-tests" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Application of principles of immunology is necessary for establishing a diagnosis of viral disease with the help of serological methods. Antibodies to many viral antigens persist in the body for a very long period extending up to months or years after encounter with the antigen. Evidence of significant increase (four fold) in the titre of antibody in paired sera is considered diagnostic of recent infection with the viral agent. In some cases, antibodies may not be present initially in the acute phase serum, but may appear a few days later. This is known as seroconversion. In such cases, infection generally represents a primary encounter with the virus.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="acute-and-convalescent-phase-sera">Acute and convalescent phase sera<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#acute-and-convalescent-phase-sera" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Whenever a patient is suspected of suffering from a viral illness, a specimen of serum in acute phase should be collected and stored at –70°C. This is of great help if viral culture fails to isolate virus or if identification of the isolate is uncertain. Under these circumstances, a convalescent phase serum may be requested 2–3 weeks after the first specimen. Demonstration of a four fold rise in titre of any antibody in paired sera can establish the diagnosis.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="single-serum">Single serum<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#single-serum" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>In some cases, a single serum sample may be examined and appropriately interpreted to reach a diagnosis. Determination of antibody titre of a particular immunoglobulin class to the suspected antigen can help in the identification of the causative agent and stage of the disease. In general, IgM antibody appears earlier than IgG. Presence of IgM antibody is of short duration, and therefore, suggests a recent or current infection. Virus specific IgM antibody usually rises during the first 2–3 weeks of infection and persists for some weeks to months, eventually being replaced with IgG antibody. Thus, a raised titre of specific IgM antibody suggests a recent primary infection by the virus, and a fall in IgM antibody in the follow up sera may further support it. For example, demonstration of IgM antibody to hepatitis A or B (core antigen) is the method of choice for establishing a recent or acute infection by these viruses.</p>
<p>Another important use of single serum is to screen neonates for certain antibodies of IgM class. IgG antibody can cross the placenta and enter passively into foetus circulation, but IgM cannot. Therefore, presence of IgG antibodies in an infant may be a result of passive transfer from mother to the foetus whereas IgM antibodies indicate active infection.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="combinations-of-serological-tests-in-viral-diseases">Combinations of serological tests in viral diseases<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#combinations-of-serological-tests-in-viral-diseases" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>When the infecting virus is not detected either by direct examination of specimens or by viral culture, paired serum samples are tested against a panel of antigens. The panel in each case is selected on the basis of:</p>
<ul>
<li>Clinical symptoms</li>
<li>Age of the patient</li>
<li>Local epidemiology of a particular virus.</li>
</ul>
<p>A few examples of such panels and tests used is listed below.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="1-acute-respiratory-infection">1. Acute respiratory infection<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#1-acute-respiratory-infection" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>(i) Influenza viruses A, B
(ii) Parainfluenza viruses
(iii) RSV
(iv) Measles viruses
(v) Adenovirus
(vi) Cytomegalovirus (CMV) in immunocompromised patient
(vii) Other non-viral antigens (Mycoplasma pneumoniae, chlamydiae and Coxiella burnetti).</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="2-acute-cns-disease">2. Acute CNS disease<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#2-acute-cns-disease" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>(i) Influenza viruses A and B
(ii) Adenovirus
(iii) Mumps virus
(iv) Measles virus
(v) Herpes simplex virus (HSV)</p>
<p>&gt; <strong>Note</strong>
&gt; Enteroviruses cause a large number of CNS diseases but multiplicity of serotypes makes it impractical to include them in a panel. Coxsackie, Echo and Polioviruses are detected by culture of throat and faecal samples.</p>
<p>Scanned by CamScanner</p>
<p>902 Medical Virology</p>
<ol start="3">
<li>
<p>Myocarditis or pericarditis
(i) Influenza A and B viruses
(ii) Adenovirus
(iii) Coxsackievirus B 1–6
(iv) <em>M. pneumoniae</em> and chlamydiae</p>
</li>
<li>
<p>Acute hepatitis
(i) Hepatitis A, B, C and E viruses
(ii) CMV
(iii) Rubella (Relative in congenital rubella)
(iv) Epstein-Barr virus (EBV)</p>
</li>
<li>
<p>Skin rashes
(i) Adenovirus
(ii) Measles virus
(iii) HSV
(iv) Varicellazoster virus (VZV)
(v) Rubella virus
(vi) CMV</p>
</li>
<li>
<p>Congenital abnormalities
(i) Rubella virus
(ii) CMV</p>
</li>
</ol>
<p>(iii) Toxoplasma gondii</p>
<p>Note
Mother’s serum should also be tested in parallel to detect antibodies passed through the placenta.</p>
<ol start="7">
<li>
<p>Pyrexia of unknown origin (PUO)
(i) As for respiratory infections
(ii) EBV
(iii) CMV
(iv) Arboviruses endemic in the area</p>
</li>
<li>
<p>Immunocompromised patients
(i) HSV
(ii) EBV
(iii) CMV
(iv) VZV
(v) Hepatitis B
(vi) HIV (Human immunodeficiency virus)</p>
</li>
</ol>
<p>The choice of serological tests for these viruses is listed in Table 3.5.</p>
<p>Scanned by CamScanner</p>
<p>Chapter 4</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h1 level="1" id="virus-vaccines-and-antiviral-therapeutic-agents">Virus Vaccines and Antiviral Therapeutic Agents<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#virus-vaccines-and-antiviral-therapeutic-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h1></div>
<p>Vaccines are available for the prevention of many human viral diseases. Vaccines may be classified into three groups:</p>
<ol>
<li>Killed virus vaccine</li>
<li>Live attenuated virus vaccine</li>
<li>Recombinant DNA produced vaccine.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="killed-virus-vaccines">KILLED VIRUS VACCINES<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#killed-virus-vaccines" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Killed virus vaccines are prepared by purifying virus cultures and then inactivating the viral infectivity in such a way that there is minimal damage to virus structural proteins. Mild formalin treatment is frequently used for this purpose. Killed virus vaccines generally result in stimulation of antibodies against virus coat proteins. These vaccines are available for viral infections such as polio, rabies, influenza, hepatitis A and some encephalitis viruses.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="disadvantages-of-killed-vaccines">Disadvantages of Killed Vaccines<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#disadvantages-of-killed-vaccines" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<ol>
<li>Immunity conferred by killed viral vaccines is usually brief, and needs to be boosted.</li>
<li>The cell-mediated immune response is generally poor.</li>
<li>Parenteral administration of killed vaccine may not stimulate IgA to provide local resistance at the site of infection, e.g. alimentary tract for polio virus, nasopharynx for respiratory viruses.</li>
<li>Some killed vaccines can induce hypersensitivity to subsequent infection as the surface antigens of virus in killed vaccine may not be exactly the same as in infection with the natural virus.</li>
<li>It is necessary to be extremely careful in the preparation so that there is no residual live virulent virus in the vaccine.</li>
</ol>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="live-attenuated-virus-vaccines">Live Attenuated Virus Vaccines<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#live-attenuated-virus-vaccines" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>Live virus vaccines make use of virus mutants which are antigenically identical with the original virus but have lost virulence. The search for such strains is done by planned, specific, genetic alterations in the laboratory. Live attenuated vaccine, when introduced into the body can simulate natural infection. The virus multiplies in the host resulting in long lasting antibody production, and induces a good cell-mediated immune response. Examples of live attenuated vaccines in use are polio, mumps, measles, rubella, adenovirus and yellow fever vaccines.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="disadvantages-of-live-attenuated-vaccines">Disadvantages of Live Attenuated Vaccines<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#disadvantages-of-live-attenuated-vaccines" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>The attenuated virus may revert to its virulent form while in the body of the host.</p>
<p>Other infectious agents latently present in cell cultures may enter the vaccine.</p>
<p>Scanned by CamScanner</p>
<p>904 Medical Virology</p>
<p>Attenuated viral vaccines have a limited shelf-life. Viral stabilizers are used in some vaccines.</p>
<p>A naturally occurring virus already present in the body may interfere with the vaccine virus, and so decrease its effectiveness.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="recombinant-dna-vaccine">RECOMBINANT DNA VACCINE<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#recombinant-dna-vaccine" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>This is a new vaccine for immunisation against Hepatitis B infection. The recombinant vaccine is produced by common baker's yeast, <em>Saccharomyces cerevisiae</em>, into which a plasmid containing the gene for HBsAg has been inserted. HBsAg is recovered by lysing the yeast cells and is separated from yeast components by hydrophobic reaction and size-exclusion chromatography.</p>
<p>The recombinant vaccine is comparable to the plasma-derived vaccine in immunogenicity. This is a recent technology that is not in common use.</p>
<p>Some vaccines used in prevention of human viral diseases are listed in Table 4.1.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="antiviral-therapeutic-agents">ANTIVIRAL THERAPEUTIC AGENTS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#antiviral-therapeutic-agents" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h3 level="3" id="interferons">Interferons<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#interferons" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h3></div>
<p>Interferons (IFN) are proteins produced by the host which can inhibit virus replication. They are believed to be body's first line of defense against viral infection. Interferons fall into three general groups, IFN-α, IFN-β and IFN-γ, and are produced by all vertebrate species when they are induced to do so by</p>
<table><thead><tr><th>Diseases</th><th>Source of vaccine</th><th>Condition of virus</th><th>Route of administration</th></tr></thead><tbody><tr><td>Poliomyelitis</td><td>Tissue culture (human diploid cell line, monkey kidney)</td><td>Live attenuated</td><td></td></tr><tr><td>Killed</td><td>Oral</td><td></td><td></td></tr><tr><td>Subcutaneous</td><td></td><td></td><td></td></tr><tr><td>Measles</td><td>Tissue culture (chick embryo)</td><td>Live attenuated</td><td>Subcutaneous</td></tr><tr><td>Mumps</td><td>Tissue culture (chick embryo)</td><td>Live attenuated</td><td>Subcutaneous</td></tr><tr><td>Rubella</td><td>Tissue culture (duck embryo, rabbit or human diploid)</td><td>Live attenuated</td><td>Subcutaneous</td></tr><tr><td>Small pox</td><td>Lymph from calf or sheep (glycerolated, lyophilized) chorioallantois, tissue cultures (lyophilized)</td><td>Live vaccinia virus</td><td>Intradermal, multiple pressure, multiple puncture</td></tr><tr><td>Yellow fever</td><td>Tissue cultures and eggs (17D strain)</td><td>Live attenuated</td><td>Subcutaneous</td></tr><tr><td>Hepatitis type B</td><td>(i) Purified HBsAg from "healthy carriers"</td><td></td><td></td></tr><tr><td>(ii) Purified HBsAg obtained by recombinant DNA technology</td><td>Killed</td><td></td><td></td></tr><tr><td>Killed</td><td>Subcutaneous</td><td></td><td></td></tr><tr><td>Intramuscular</td><td></td><td></td><td></td></tr><tr><td>Influenza</td><td>Highly purified or subunit forms of chick embryo allantoic fluid (formalin-treated or UV-irradiated)</td><td>Killed</td><td>Subcutaneous or intradermal</td></tr><tr><td>Rabies</td><td>Duck embryo or human diploid cells</td><td>Killed</td><td>Subcutaneous</td></tr><tr><td>Adenovirus Infections</td><td>Human diploid cells cultures</td><td>Live attenuated</td><td>Oral, by enteric-coated capsule</td></tr></tbody></table>
<p>Scanned by CamScanner</p>
<p>Virus Vaccines and Antiviral Therapeutic Agents 905</p>
<p>viruses. Bacterial endotoxins and some small molecules such as tilorone also induce interferons.</p>
<p>The different classes of interferons are produced by different cell types, e.g. IFN-α are produced by leukocytes, IFN-β by fibroblasts and IFN-γ by lymphocytes. Interferons are produced within 48 hours of viral infection and reduce the rate of multiplication of the virus. Virus specific antibody on the other hand, appears in hosts' blood several days after virus entry. Interferon therefore, plays a primary role in host defense against viral infections.</p>
<p>Interferon activity is not specific for a virus. The mechanism of its action is poorly understood. It binds to surface receptors in a cell which triggers the synthesis of several enzymes. These enzymes block viral multiplication by inhibiting the translation of viral mRNA into viral protein. Interferons are also involved in regulation of cell growth and differentiation. They enhance natural killer cell activity in the body.</p>
<p>Interferons are not generally used for protection against viral infection because they need to be given in high doses at which they exhibit toxic side effects such as bone marrow suppression. They may also affect nervous and gastrointestinal systems.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="immune-globulin">Immune Globulin<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#immune-globulin" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>It is a preparation of gamma globulin derived from large pools of human plasma, and contains a high concentration of antibody containing globulins. Immune globulin can be used clinically in viral diseases such as measles and hepatitis A to attenuate the disease and to prevent clinical disease in non-immunized children.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="specific-human-gamma-globulins">Specific Human Gamma Globulins<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#specific-human-gamma-globulins" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>These are obtained from the blood of individuals who have been immunized with a given antigen and have acquired a high concentration of specific antibody. It is found to be effective against rabies, mumps, chicken-pox and hepatitis B infection.</p>
<div data-testid="stHeadingWithActionElements" class="st-emotion-cache-1p9ibxm e1icttdg2"><h2 level="2" id="b29219fe">♦ ANTI-VIRAL DRUGS<span data-testid="stHeaderActionElements" class="st-emotion-cache-gi0tri e1icttdg3"><a href="#b29219fe" class="st-emotion-cache-yinll1 e1icttdg1"><svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2" stroke-linecap="round" stroke-linejoin="round"><path d="M15 7h3a5 5 0 0 1 5 5 5 5 0 0 1-5 5h-3m-6 0H6a5 5 0 0 1-5-5 5 5 0 0 1 5-5h3"></path><line x1="8" y1="12" x2="16" y2="12"></line></svg></a></span></h2></div>
<p>As viruses are obligate intracellular parasites, antiviral agents must be capable of selectively inhibiting viral functions without damaging the host cells. The majority of antiviral drugs in use are nucleoside analogs. They inhibit nucleic acid replication by (1) inhibition of enzymes of the metabolic pathway for purines and pyrimidines, or (2) by inhibition of polymerases for nucleic acid replication. However, these analogs can inhibit virus coded enzymes as well as enzymes of the host cell. They can be used for antiviral treatment only if the benefit of virus inhibition is greater than its toxicity to the host cell.</p>
<p>Acyclovir is an analog of guanosine which strongly inhibits herpes simplex virus, but has little effect on other DNA viruses or on host cells. Vidarabine is a purine analog effective against herpes simplex and varicella zoster infections. Other drugs such as Idoxuridine, Trifluridine, Ribavirin etc. also have similar effects. Some are useful only for topical application.</p>
<p>Amantatidine is effective against influenza A virus and acts by blocking viral penetration into the host cell.</p>
<p>Enviroxine inhibits rhinovirus in cell culture and reduces common cold symptoms in human hosts. Other drugs include Arildone, Methisazone and Phosphonoacetic acid.</p>
<p>Acidothymidine (Zidovudine), dideoxycytosine (ddc) and dideoxyinosine (ddI) are nucleoside analogs which inhibit reverse transcriptase enzyme of HIV.</p>
<p>Scanned by CamScanner</p></div></div></div></div></div></div></div><div data-testid="stAppIframeResizerAnchor" data-iframe-height="true" class="st-emotion-cache-1dumvfu eht7o1d9"></div></section></div></div></div><div data-testid="portal" id="portal" class="st-emotion-cache-1q6lfs0 e19n7mk11"></div></div><div class=""></div></div>
  

</body></html>